Biodegradable wool fabrics for oral products
By using a woolen fabric material with specific fiber types and biodegradable adhesives to wrap oral products, the problem of insufficient biodegradability of existing products is solved, resulting in oral products that are rapidly degradable and environmentally friendly.
Patent Information
- Application Number
- CN202480088253.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-12-20
- Filing Date
- 2024-12-19
- Publication Date
- 2026-11-17
AI Technical Summary
Existing oral care products are not biodegradable enough, making it difficult to effectively reduce environmental pollution after use.
Using a woolen fabric material containing specific fiber types and a biodegradable adhesive, an external water-permeable pouch is formed to encapsulate the oral composition and enhance its biodegradability.
It achieves rapid degradation after use, reducing environmental pollution and improving product sustainability.
Smart Images

Figure CN123124887A_ABST
Abstract
Description
[0001] Cross-references to related applications
[0002] This application claims priority to patent application number GB2319623.1, filed on December 20, 2023, the entire contents of which are incorporated herein by reference. Technical Field
[0003] This disclosure relates to oral products intended for human use. The products are configured for oral use and deliver substances such as flavoring agents and / or active ingredients during use. Such products may include tobacco or tobacco-derived products, or may be tobacco-free alternatives. Background Technology
[0004] There are many product categories designed for oral use and enjoyment. For example, oral tobacco products containing nicotine, which is known to have both stimulant and anti-anxiety properties, have been available for many years. Traditional forms of so-called "smokeless" tobacco products include snuff, snus, and chewing tobacco, which are typically made almost entirely of particulate, granular, or fragmented tobacco and are either dispensed by the user or provided to the user in individual portions (such as in single-use pouches or sachets). See, for example, the types, ingredients, and processing methods of smokeless tobacco formulations described in the following patents: U.S. Patent No. 6,668,839 to Williams; U.S. Patent No. 6,834,654 to Williams; U.S. Patent No. 6,953,040 to Atchley et al.; U.S. Patent No. 7,032,601 to Atchley et al.; U.S. Patent No. 7,694,686 to Atchley et al.; U.S. Patent No. 7,810,507 to Dube et al.; U.S. Patent No. 7,819,124 to Strickland et al.; U.S. Patent No. 7,861,728 to Holton, Jr. et al.; U.S. Patent No. 7,901,512 to Quinter et al.; U.S. Patent No. 8,627,828 to Strickland et al.; and U.S. Patent No. 11,246,334 to Atchley, each of which is incorporated herein by reference.
[0005] In addition, traditional tobacco and non-tobacco materials have been combined with other ingredients to form product forms that differ from traditional smokeless products, such as lozenges, tablets, gels, etc. See, for example, the product types described in the following patents: U.S. Patent Application Publication No. 2008 / 0196730, Engstrom et al.; U.S. Patent Application Publication No. 2008 / 0305216, Crawford et al.; U.S. Patent Application Publication No. 2009 / 0293889, Kumar et al.; U.S. Patent Application Publication No. 2010 / 0291245, Gao et al.; U.S. Patent Application Publication No. 2011 / 0139164, Mua et al.; U.S. Patent Application Publication No. 2012 / 0037175, Cantrell et al.; U.S. Patent Application Publication No. 2012 / 0055494, Hunt et al.; U.S. Patent Application Publication No. 2012 / 0138073, Cantrell et al.; U.S. Patent Application Publication No. 2012 / 0138074, Cantrell et al.; U.S. Patent Application Publication No. 2013 / 0074855, Holton, Jr.; Holton, The following U.S. Patent Application Publication No. 2013 / 0074856 by Jr.; U.S. Patent Application Publication No. 2013 / 0152953 by Mua et al.; U.S. Patent Application Publication No. 2013 / 0274296 by Jackson et al.; U.S. Patent Application Publication No. 2015 / 0068545 by Moldovanu et al.; U.S. Patent Application Publication No. 2015 / 0101627 by Marshall et al.; and U.S. Patent Application Publication No. 2015 / 0230515 by Lampe et al. are each incorporated herein by reference.
[0006] There is a growing interest in developing new types of oral products that deliver beneficial sensory or biological activity. These products typically contain flavoring agents and / or active ingredients such as nicotine, caffeine, or botanical materials. In one form, such products are packaged as pouches containing powdered or granular compositions. See, for example, U.S. Patent Application Publication No. 2023 / 0049343 by Keller et al.; U.S. Patent Application Publication No. 2022 / 0071984 by Poole et al.; U.S. Patent Application Publication No. 2021 / 0330590 by Hutchens et al.; U.S. Patent Application Publication No. 2021 / 0186081 by Gerardi et al.; U.S. Patent Application Publication No. 2021 / 0177754 by Keller et al.; U.S. Patent Application Publication No. 2021 / 0177043 by Gerardi et al.; and U.S. Patent Application Publication No. 2021 / 0169867 by Holton, Jr. et al., all of which are incorporated herein by reference.
[0007] Brief Overview
[0008] According to this disclosure, an oral product with enhanced degradation properties (e.g., a pouch-type oral product) is provided. In some embodiments, enhanced biodegradability is achieved by selecting specific fiber types included in the fleece material used to encapsulate the oral composition. Alternatively or additionally, in some embodiments, enhanced biodegradability is provided by using a biodegradable adhesive material. Therefore, this document provides unique fleece compositions, corresponding oral products, and methods for preparing such compositions and fleece.
[0009] This disclosure includes, but is not limited to, the following implementation methods: Embodiment 1: A bagged product comprising: an external water-permeable pouch defining a cavity and a composition containing at least one water-soluble component within the cavity, wherein the external water-permeable pouch comprises a woolen fabric material comprising a plurality of fibers, wherein the plurality of fibers comprises one or more structural fiber materials; and wherein the external water-permeable pouch further comprises one or more biodegradable components selected from: a plurality of fiber materials comprising thermoplastic starch and / or polyhydroxyalkanoates; and a biodegradable adhesive component associated with the plurality of fibers.
[0010] Embodiment 2: The bagged product as described in Embodiment 1, wherein the plurality of fibers comprises one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates, and wherein the one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates are contained within the same fiber.
[0011] Embodiment 3: A bagged product as described in Embodiment 1 or 2, wherein the plurality of fibers include fibers in the form of a sheath / core structure, the sheath component comprising thermoplastic starch and / or polyhydroxyalkanoates surrounding the core component, the core component comprising one or more structural fiber materials.
[0012] Embodiment 4: The bagged product as described in Embodiment 3, wherein the core component comprising one or more structural fiber materials includes natural fiber materials selected from cotton, wool, cellulose or cellulose derivatives (e.g., regenerated cellulose), particularly wherein the core component comprises cellulose.
[0013] Embodiment 5: The bagged product as described in any one of Embodiments 1-4, wherein one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates are in the form of a blend.
[0014] Embodiment 6: A bagged product as described in any one of Embodiments 1-5, wherein the plurality of fibers comprises one or more structural fiber materials and the thermoplastic starch and / or polyhydroxyalkanoates, and wherein the one or more structural fiber materials and the thermoplastic starch and / or polyhydroxyalkanoates are contained in different fibers, particularly wherein each different fiber is selected from single-component fibers and multi-component fibers.
[0015] Embodiment 7: A bagged product as described in any one of Embodiments 1-6, wherein the polyhydroxyalkanoate is selected from poly(3-hydroxybutyrate) (P(3HB)), poly(4-hydroxybutyrate) (P(4HB)) and poly(3-hydroxyvalerate) and their copolymers, derivatives and blends.
[0016] Embodiment 8: The bagged product as described in Embodiment 7, wherein the polyhydroxyalkanoate is selected from poly-3-hydroxybutyrate-co-4-hydroxybutyrate, poly-3-hydroxybutyrate-co-valerate and polyhydroxybutyrate-co-hexanoate, and blends of two or more thereof.
[0017] Embodiment 9: The bagged product as described in any one of Embodiments 1-8, wherein the polyhydroxyalkanoate is selected from: short-chain PHA (SCL-PHA) having 3-5 carbon atoms in the monomer unit; medium-chain PHA (MCL-PHA) having 6-14 carbon atoms in the monomer unit; and long-chain PHA (LCL-PHA) having more than 14 carbon atoms in the monomer unit.
[0018] Embodiment 10: A bagged product as described in any one of Embodiments 1-9, comprising a plurality of fibrous materials including thermoplastic starch and / or polyhydroxyalkanoates, comprising: a first plurality of fibers comprising a first polyhydroxyalkanoate having a first melting point, and a second plurality of fibers comprising a second polyhydroxyalkanoate having a second melting point different from the first melting point.
[0019] Implementation method 11: The bagged product as described in implementation method 10, wherein the first melting point and the second melting point differ by at least about 10°C.
[0020] Implementation method 12: The bagged product as described in implementation method 10 or 11, wherein the first melting point is below 75°C and the second melting point is above 125°C.
[0021] Embodiment 13: A bagged product as described in any one of Embodiments 10-12, wherein the first plurality of fibers includes a first sheath component surrounding a first core component, wherein the first sheath component includes a first polyhydroxyalkanoate, the second plurality of fibers includes a second sheath component surrounding a second core component, and wherein the second sheath component includes a second polyhydroxyalkanoate.
[0022] Embodiment 14: The bagged product as described in Embodiment 13, wherein the first core component and / or the second core component comprises a natural fiber material selected from cotton, wool, cellulose or cellulose derivatives (e.g., regenerated cellulose), and in particular, wherein the natural fiber material comprises cellulose.
[0023] Embodiment 15: The bagged product as described in any one of Embodiments 1-14, wherein the thermoplastic starch comprises one or more starches derived from corn, cassava, wheat, rye, peas, sorghum, cassava, rice, calathea, sugar palm, or potato.
[0024] Embodiment 16: A bagged product as described in any one of Embodiments 1-15, wherein one or more structural fiber materials are selected from cotton, wool, cellulose and cellulose derivatives (e.g., regenerated cellulose).
[0025] Embodiment 17: The bagged product as described in any one of Embodiments 1-16 contains a biodegradable adhesive component, particularly wherein the biodegradable adhesive component is derived from sources selected from corn or corn starch, potatoes, cassava, bagasse, algae, fruit peels, shrimp shells, and combinations thereof, and particularly wherein the biodegradable adhesive component includes modified biopolymers and natural plant compounds.
[0026] Embodiment 18: A bagged product as described in any one of Embodiments 1-17, wherein the woolen material and / or the bagged product is substantially free of TiO2.
[0027] Embodiment 19: The bagged product as described in any one of Embodiments 1-18, wherein the woolen fabric material is mainly composed of one or more structural materials and one or more biodegradable components.
[0028] Embodiment 20: A bagged product as described in any one of Embodiments 1-18, wherein the woolen fabric material includes one or more additional components (e.g., additional fibers) in addition to one or more structural materials and one or more biodegradable components.
[0029] Embodiment 21: The bagged product as described in Embodiment 20, wherein one or more additional components include biodegradable cellulose acetate fibers.
[0030] Embodiment 22: A bagged product as described in any one of Embodiments 1-21, wherein the oral composition comprises at least one of an active agent and a flavoring agent in an amount of at least about 0.5% by weight of the oral composition; and a filler in an amount of at least about 30% by weight of the oral composition.
[0031] Embodiment 23: The bagged product as described in Embodiment 22, wherein the filler is selected from sugar substitutes, microcrystalline cellulose and combinations thereof.
[0032] Embodiment 24: A bagged product as described in any one of Embodiments 1-23, wherein the woolen fabric material exhibits biodegradability according to one or more of ASTM D5338, ASTM D5511, ASTM D5526, D5988, ASTM D6400 and ASTM D6691.
[0033] These and other features, aspects, and advantages of this disclosure will become apparent from the following detailed description of embodiments, taken in conjunction with the accompanying drawings, which are briefly described below. This disclosure includes any combination of two, three, four, or more of the embodiments described above, as well as any combination of two, three, four, or more features or elements shown in this disclosure, whether or not such features or elements are explicitly combined in the detailed description herein. This disclosure is intended to be read holistically, such that any separable feature or element in any of its various aspects and embodiments should be considered as intended to be composable unless the context clearly specifies otherwise. Attached Figure Description
[0034] Having given a general overview of various aspects of this disclosure above, the description will now take place with reference to the accompanying drawings, which are not necessarily drawn to scale. The drawings are merely illustrative and should not be construed as limiting the scope of this disclosure.
[0035] Figure 1 This is a perspective view of a non-limiting wool-based bagged product according to some embodiments of the present disclosure; Figure 2 This is a table of certain non-limiting exemplary woolen fabrics and their components according to some embodiments of this disclosure. Detailed Implementation
[0036] The invention will now be described in more detail below. However, this disclosure may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure is thorough and complete, and fully demonstrates its scope to those skilled in the art. The singular forms “a,” “an,” and “the” used in the specification and claims include the plural forms unless the context clearly specifies otherwise. References to “percentage by dry weight” or “based on dry weight” mean based on the weight of the dry components (i.e., all components except water). References to “wet weight” mean the weight of a mixture including water. Unless otherwise stated, references to a mixture as a “percentage by weight” reflect the total wet weight of the mixture (i.e., including water).
[0037] woolen fabrics
[0038] This invention generally provides textile materials suitable for, for example, formulations for oral use. The term "formulated for oral use" as used herein refers to a product provided in such a form that, during use, saliva in the user's mouth causes one or more components of the product (e.g., flavoring agents and / or active ingredients) to enter the user's mouth. In some embodiments, the product is adapted to deliver one or more components to the user through the user's oral mucosa, wherein said components are, in some cases, active ingredients (including, but not limited to, nicotine), which can be absorbed through the oral mucosa when the product is used. As described in this document, the product is typically in pouch form. A pouch product refers to a product comprising an externally water-permeable container in the form of a pouch containing material suitable for oral use (e.g., a granular mixture suitable for oral use). The orientation, size, composition, and type of externally water-permeable pouches shown herein, as well as the type and properties of compositions suitable for oral use, should not be construed as limiting thereto.
[0039] More specifically, this invention provides woven fabric materials (such as those used for bagged products) for use as external water-permeable containers, having unique composition and / or properties, particularly exhibiting enhanced biodegradability (e.g., compared to conventional woven fabric materials). As used herein, “woven fabric material” can be formed from various types of fibers (described in more detail below) capable of forming woven fabrics or other pouch materials. For example, woven fabric materials can be provided in the form of woven or nonwoven fabrics (e.g., dry-laid webs (e.g., carded and / or short-fiber air-laid webs), wet-laid webs or paper webs prepared by papermaking machine technology). Various types of woven fabric materials are described, for example, in U.S. Patent No. 8,931,493 to Sebastian et al.; U.S. Patent Application Publication No. 2015 / 0128978 to Sebastian et al.; U.S. Patent Application Publication No. 2016 / 0000140 to Sebastian et al.; and U.S. Patent Application Publication No. 2016 / 0073689 to Sebastian et al., all of which are incorporated herein by reference.
[0040] Wool fabrics are typically nonwoven webs of fibers, containing multiple fibers. As used herein, the term "fiber" is defined as a fundamental element of textiles. Fibers are typically in the form of rope-like or cord-like elements. As used herein, the term "fiber" is intended to include fibers, filaments, continuous filaments, staple fibers, etc. The term "multicomponent fiber" refers to a fiber containing two or more components with different physical or chemical properties, including bicomponent fibers. Specifically, the term "multicomponent fiber" includes both staple and continuous fibers prepared from two or more polymers present in discrete structural domains within the fiber, unlike blends where the phase regions are often dispersed, random, or unstructured.
[0041] The term "nonwoven" is used herein to refer to fibrous materials, webs, mats, wadding, or sheets in which fibers are arranged in an undefined or random orientation. Nonwoven fibers initially exist as unbonded fibers or filaments. A key step in the manufacture of nonwoven fabrics involves bonding various fibers or filaments together. The methods of bonding fibers or filaments can vary and include thermal, mechanical, and chemical techniques, which are selected in part depending on the desired properties of the final product, as discussed in more detail below.
[0042] In some embodiments, this document provides textile materials comprising one or more components (e.g., fibers and / or adhesives) including one or more biodegradable materials (e.g., plastic materials), including compostable and / or oxidatively degradable plastic materials (broadly referred to herein as "biodegradable"). The term "biodegradable" as used with respect to plastic materials refers to a polymer that degrades to carbon dioxide / methane, water, and biomass in the presence of bacteria, fungi, algae, and / or other microorganisms under aerobic and / or anaerobic conditions, although materials containing heteroatoms may also produce other products such as ammonia or sulfur dioxide. "Biomass" generally refers to a portion of metabolic material incorporated into the cellular structure of an existing organism or transformed into a humic component indistinguishable from biologically derived materials. "Compostable" means the material is designed to biodegrade under composting facility conditions (e.g., at temperatures below those of industrial composting facilities), and "oxidatively degradable" means the material (typically containing suitable additives) breaks down into microplastics or decomposes through oxidative chemical degradation. In some embodiments, biodegradable fibers are biologically based (i.e., made entirely or partially from biological raw materials rather than from fossil fuel-based materials used in conventional plastics), although biodegradable plastic materials (and this disclosure) are not limited thereto.
[0043] Therefore, this disclosure provides at least partially biodegradable woolen fabric materials, and oral products comprising at least partially biodegradable woolen fabric materials (wherein at least the outer woolen fabric material or a portion thereof of the oral product is biodegradable, for example, after use of the oral product). Biodegradability can be measured by placing a sample under environmental conditions that are expected to lead to decomposition, such as placing the sample in water, a solution containing microorganisms, compost material, or soil. The degree of degradation can be characterized by the weight loss of the sample after exposure to given environmental conditions for a period of time. Exemplary degradation rates of certain woolen fabrics (and oral products) of this disclosure include at least about 20% weight loss after burial in soil for 60 days, or at least about 30% weight loss after exposure to a typical municipal composting facility for 15 days. However, biodegradation rates may vary depending on the type and amount of biodegradable plastic material used, the remaining composition of the woolen fabric (and / or oral product), and the environmental conditions associated with the degradation test. Non-limiting examples of test conditions for degradation testing are provided in U.S. Patent No. 5,970,988 to Buchanan et al. and U.S. Patent No. 6,571,802 to Yamashita. The degradability of plastic materials can also be determined using one or more of the following ASTM test methods: ASTM D5338, ASTM D5511, ASTM D5526, D5988, ASTM D6400, and ASTM D6691.
[0044] At least partially biodegradable woolen materials may contain one or more biodegradable components, and in some embodiments, are substantially composed of biodegradable components. Such biodegradable components may include biodegradable fibers (e.g., structural fibers, fibers for web bonding, and / or fibers for bag heat sealing) and / or biodegradable adhesive materials (e.g., which can be used as components for web bonding and / or bag heat sealing because partially uncrosslinked bonds can be retained for bag heat sealing). Non-limiting woolen materials provided herein include, but are not limited to, those described herein. Figure 2 The example materials provided are shown below. Example A is a woolen fabric material that comprises one or more structural fibers and one or more T-shaped fibers suitable for web bonding. m1 Functional fibers and one or more T-type fibers suitable for bag heat sealing m2 Functional fibers. Example B is a woolen fabric material comprising one or more structural fibers, one or more biodegradable adhesives suitable for web consolidation, and one or more T-type fibers suitable for bag heat sealing. m2 Functional fibers. Example C is a woolen fabric material comprising one or more structural fibers and one or more biodegradable adhesives, wherein the biodegradable adhesives are used for web consolidation, and a portion thereof is retained in the form of uncrosslinked bonds for use in bag heat sealing. Other combinations of structural fibers, components for web consolidation, and components for bag heat sealing are also contemplated herein.
[0045] Examples of biodegradable materials that can be used in the fibrous form in various woolen fabric materials provided according to this disclosure include, for example, cellulose acetate (“CA”), thermoplastic starch (“TPS”), and polyhydroxyalkanoates (“PHA”). These biodegradable materials can be incorporated into the fibers of woolen fabric materials in various ways, including but not limited to the form of monopolymer fibers (e.g., fibers without additional component polymer materials, such as those consisting essentially of biodegradable materials) or multipolymer fibers (e.g., fibers containing biodegradable materials and one or more additional component polymer materials).
[0046] Monopolymer fibers can be used alone or in combination with one or more other types of fibers, which contain one or more additional component polymer materials to produce the disclosed woolen fabric material. In some embodiments, one or more other types of fibers are structural fibers, which are included to provide structure to the woolen fabric material; non-limiting examples of such other types of fibers are natural fibers and regenerated cellulose fibers, such as viscose fibers, lyocell fibers, etc.
[0047] Polymer fibers can include, for example, blends of biodegradable materials and one or more other component polymer materials, or can include multi-component fibers, including but not limited to fibers with a sheath / core structure and fibers with an island structure, as well as fibers with a side-by-side, split disc, split cross, split band, or pointed multi-leaf cross-section. In some embodiments, the fibers are in a core-sheath configuration, for example, where the biodegradable plastic material is the core or where the biodegradable plastic material is the sheath (where the other components are any other materials, including but not limited to the polymer types referred to below). Similarly, like monopolymer fibers, polymer fibers can be used alone or in combination with one or more other types of fibers containing one or more additional component polymer materials to produce the disclosed woolen fabric material. In some embodiments, one or more other types of fibers are structural fibers, included to provide structure to the woolen fabric material; non-limiting examples of such other types of fibers are natural fibers and regenerated cellulose fibers, such as viscose fibers, lyocell fibers, etc.
[0048] In some embodiments, biodegradable plastic materials include one or more cellulose acetates; therefore, the present invention provides a textile material (and oral products) comprising fibers containing one or more cellulose acetates. Cellulose acetate is a polymer produced by esterifying the hydroxyl groups on cellulose (such as those derived from wood fibers or cotton) with acetate. Non-limiting examples of CA include cellulose triacetate (where almost all hydroxyl groups are modified with acetic acid) and cellulose diacetate (where some of the hydroxyl groups are unmodified). Cellulose acetate can be highly biodegradable, for example in soil and ocean / seawater, typically degraded into cellulose and acetic acid through hydrolysis and biodegradation by esterases. The cellulose backbone is biodegraded (cleaved / decomposed) by cellulases, which can convert it into water and carbon dioxide.
[0049] In some embodiments, the biodegradable plastic material comprises one or more thermoplastic starches, and thus the present invention provides a textile material (and oral products) comprising fibers containing one or more thermoplastic starches. TPS can be derived from a variety of starch sources, such as, but not limited to, starches derived from corn, cassava, wheat, rye, peas, sorghum, rice, arrowroot, sugar palm, potatoes, etc. Such starch sources are typically modified (e.g., by adding plasticizers, including but not limited to glycerol, sorbitol, or certain ionic liquids) to produce TPS; an exemplary non-limiting method for producing TPS from natural starch using plasticizers is provided in International Patent Application Publication No. WO1990 / 05161 (which is incorporated herein by reference in its entirety).
[0050] In some embodiments, a woolen fabric material is provided comprising fibers containing one or more PHAs. PHAs are polyesters typically produced in nature by microorganisms (e.g., through bacterial fermentation of sugars or lipids). More specifically, PHAs are the polyhydroxy ester family of 3-, 4-, 5-, and 6-hydroxyalkanoic acids. The composition and structure of PHAs can vary; certain non-limiting examples of PHAs include poly(3-hydroxybutyrate) (P(3HB)), poly(4-hydroxybutyrate) (P(4HB)), and poly(3-hydroxyvalerate) and their copolymers and derivatives (e.g., including poly-3-hydroxybutyrate-co-4-hydroxybutyrate, poly-3-hydroxybutyrate-co-valerate, and polyhydroxybutyrate-co-hexanoate). PHAs can vary, for example, in terms of the number of carbon atoms in the constituent monomer units and the total length of the polymer chains (leading to variations in physical properties, including T...). m PHA is generally classified into short-chain PHA (SCL-PHA) with 3-5 carbon atoms in the monomer unit, medium-chain PHA (MCL-PHA) with 6-14 carbon atoms in the monomer unit, and long-chain PHA (LCL-PHA) with more than 14 carbon atoms in the monomer unit.
[0051] In some embodiments, the disclosed woolen fabric material comprises two or more types of fibers, including a first plurality of fibers and a second plurality of fibers, wherein the first plurality of fibers comprises one or more biodegradable plastic materials and has a first melting point T. m1 The second plurality of fibers comprises one or more biodegradable plastic materials and has a second melting point T. m2 Melting points of various plastic materials are known in the art, and as used herein, melting can refer to the temperature at which a portion of a surface layer melts (e.g., at the surface between two adjacent material layers), the entire surface layer melts, or the entire layer melts. In these embodiments, two or more types of fibers may comprise the same biodegradable plastic material, or they may comprise different biodegradable plastic materials. In some embodiments, one type of fiber may be used as an adhesive fiber, as will be described in further detail below.
[0052] In some implementations, T m1 and T m2 Advantageously, the phase difference is large enough that, in the presence of two or more types of biodegradable plastic material fibers, the first plurality of fibers can be used as adhesive fibers for web consolidation (e.g., at melting point T). m1 or above but below the melting point T m2 The second multiple fibers can be added after filling, i.e., after adding the oral composition disclosed below (e.g., at melting point T). m2(or higher), the bagged product is heat-sealed. In such an embodiment, it is advantageous that at T m1 Heating the first plurality of fibers or more may not significantly affect the second plurality of fibers. For example, in some embodiments, T m2 T m1 Temperatures 10°C or higher, for example, higher than T m1 More than 15°C higher than T m1 More than 20°C higher than T m1 More than 30°C higher than T m1 More than 40°C higher than T m1 More than 50°C higher than T m1 More than 60°C higher than T m1 Temperatures above 70°C, higher than T m1 Temperatures above 80°C, higher than T m1 Temperatures above 90°C or higher than T m1 Temperatures are more than 100°C higher.
[0053] In some embodiments, both the first and second plurality of fibers comprise PHA. The melting point of the PHA can vary, for example from about 40°C to about 180°C (e.g., in some non-limiting examples, the melting point is about 40°C to about 60°C, such as 43.2-51.2°C, or about 170-180°C, such as 173-180°C). In one embodiment, the first plurality of fibers comprises a core-sheath fiber having PHA as a sheath, and the second plurality of fibers comprises a core-sheath fiber with PHA (having a different melting point) as a sheath. The core can vary; in some embodiments, the core comprises a natural fibrous material selected from cotton, wool, cellulose, or cellulose derivatives (e.g., regenerated cellulose). As a non-limiting embodiment... In a regulatory example, the first plurality of fibers may comprise PHA with a melting point of about 40°C to about 60°C, such as P(4HB) with a melting point of about 60°C, and the second plurality of fibers may comprise PHA with a melting point of about 170-180°C, such as P(3HB) with a melting point of about 170-180°C. In some such embodiments, the core of each of these fibers is a natural fibrous material, such as, but not limited to, cellulose. Those skilled in the art will recognize that the melting point can be adjusted, for example, by selecting suitable polymers and / or copolymerizing the polymers with each other or with other polymers, to change the melting point as needed.
[0054] The total content of biodegradable plastic fibers in a given wool fabric material can vary considerably. In some embodiments, a wool fabric material is provided comprising at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, at least about 95%, or at least about 99% of biodegradable plastic materials, for example, about 20% to about 100%, about 20% to about 80%, about 50% to about 100%, or about 50% to about 80% of biodegradable plastic materials, based on the total weight of fibers within the wool fabric material. It is understood that the percentage of biodegradable fibers in a wool fabric material directly affects its biodegradability; that is, the higher the content of biodegradable fibers, the greater the biodegradability of the wool fabric material.
[0055] In some embodiments, the woolen fabric material comprises only biodegradable fibers. In some embodiments, the woolen fabric material comprises one or more other component materials as described above. Where other components are present, these other component materials in the woolen fabric material provided herein are not particularly limited. In some embodiments, other component materials within the woolen fabric material include, but are not limited to, polymers selected from the group consisting of: polyglycolic acid, polylactic acid, polyhydroxyalkanoates, polycaprolactone, polybutylene succinate, polybutylene adipate, polyvinylpyrrolidone, polyvinyl alcohol, and combinations and copolymers thereof. In some embodiments, other component fibers within the woolen fabric material may be selected from the group consisting of: wool, cotton, fibers made from cellulose materials (such as regenerated cellulose, cellulose acetate, cellulose triacetate, cellulose nitrate, ethyl cellulose, cellulose acetate propionate, cellulose acetate butyrate, hydroxypropyl cellulose, methyl hydroxypropyl cellulose), protein fibers, etc. See also the fiber types shown in U.S. Patent Application Publication No. 2014 / 0083438, by Sebastian et al., which is incorporated herein by reference. In some embodiments, optional additional component materials within the woolen fabric material include regenerated cellulose fibers, which can be formed by extracting a non-cellulose compound from wood, contacting the extracted wood with caustic soda, and then sequentially contacting it with carbon disulfide and sodium hydroxide to produce a viscous solution. This solution is then forced through a spinneret to produce viscous filaments of the regenerated fibers. Exemplary methods for preparing regenerated cellulose are provided in U.S. Patent No. 4,237,274 to Leoni et al.; U.S. Patent No. 4,268,666 to Baldini et al.; U.S. Patent No. 4,252,766 to Baldini et al.; U.S. Patent No. 4,388,256 to Ishida et al.; U.S. Patent No. 4,535,028 to Yokogi et al.; U.S. Patent No. 5,441,689 to Laity; U.S. Patent No. 5,997,790 to Vos et al.; and U.S. Patent No. 8,177,938 to Sumnicht, all of which are incorporated herein by reference. The methods for preparing regenerated cellulose are not limited and can include, for example, both the rayon process and the lyocell process. Various suppliers of regenerated cellulose are known, including Lenzing (Austria), Cordenka (Germany), AdityaBirla (India), and Daicel (Japan).
[0056] Fibers comprising one or more biodegradable plastic materials may contain varying amounts of the biodegradable plastic material. For example, in some embodiments, the fiber is substantially composed of or composed of the biodegradable plastic material. In some embodiments, the fiber includes the biodegradable plastic material as a major component (e.g., 50% or more of the fiber volume). In some embodiments, the fiber includes the biodegradable plastic material as a non-major component (e.g., less than 50% of the fiber volume). Fibers used in woolen fabrics can have any type of cross-section, including but not limited to circular, rectangular, square, elliptical, triangular, and multi-lobed shapes. In some embodiments, the fiber may have one or more void spaces, wherein the void spaces may have, for example, circular, rectangular, square, elliptical, triangular, or multi-lobed cross-sections. In some embodiments, the fiber may include grooves or channels (e.g., having a 4DG, Killat N, trefoil, or double-sector cross-section; see, for example, EP2635142, the entire contents of which are incorporated herein by reference).
[0057] The physical parameters of the fibers present in a nonwoven web can vary. For example, fibers used in woolen materials can have different dimensions (e.g., length, denier (dpf)) and crimp characteristics. In some embodiments, the fibers used in the nonwoven web can be nanofibers, submicron fibers, and / or micron-sized fibers. In some embodiments, the fibers of the nonwoven web used herein can be measured to be from about 1.5 dpf (1.67 dtex) to about 2.0 dpf (2.22 dtex), or from about 1.6 dpf (1.78 dtex) to about 1.90 dpf (2.11 dtex). In some embodiments, each fiber can have about 4-10 crimps / cm or about 5-8 crimps / cm. In some embodiments, each fiber can be a continuous filament fiber. In some embodiments, each fiber can be a short fiber. The (measured) length of each fiber can be from about 35 mm to about 60 mm, or, for example, from about 38 mm to about 55 mm. In some implementations, it may be advantageous to have all fibers in the woolen material have similar fiber size and crimp properties to ensure good mixing and orientation of fibers in the nonwoven web.
[0058] In some embodiments, a heat-sealable adhesive coating or adhesive material (e.g., a coating or other additive) may be added to the fibers before, during, or after the formation of the woven material. As used herein, a “heat-sealable adhesive coating” refers to a coating material, such as an acrylic polymer composition, applied to a substrate (e.g., a nonwoven web or woven material) that is capable of sealing the seams of individual pouches upon heating. In some embodiments, the adhesive material may be added to the web fibers before or during the laying of the web (i.e., before the web is bonded to form the woven material). In some embodiments, the adhesive material may be added to the woven material after its formation. In some embodiments, the adhesive material is in the form of a liquid coating. In some embodiments, an adhesive powder may be applied to the woven material. For example, powdered polyethylene may be used as an adhesive material. For example, a liquid or powder coating may be applied between fiber layers during cross-laying, air-laid web formation, or as a post-treatment. Brief exposure in an oven is sufficient to melt and fuse the adhesive material.
[0059] While conventional adhesives can be used in some embodiments within the context of the woolen materials and oral products disclosed herein, adhesives typically increase the content of non-biodegradable substances. Therefore, in some embodiments, it may be advantageous to further enhance the biodegradability of the woolen materials and / or oral products by avoiding the use of such adhesive materials. In some embodiments, this can be achieved by employing alternative adhesives. In such embodiments, at least a portion of the conventional chemical adhesive (e.g., which may include polymers such as ethylene / vinyl acetate) is replaced by an alternative adhesive. The alternative adhesive includes biodegradable adhesive components, such as “bioadhesives,” whose bio-derived components can be up to 100% (including 100%), and may include biopolymers and other bio-derived components (e.g., organic acids and proteins). In some embodiments, such bioadhesives are referred to as substantially or completely “plastic-free” or “fossil fuel-free materials,” for example, because they are prepared from raw materials other than fossil fuels.
[0060] Bioadhesives can be produced from a variety of sources, including but not limited to renewable sources such as corn starch, potatoes, cassava, bagasse, and algae. According to some embodiments, a suitable class of non-limiting materials suitable for use as adhesives is the OC-BioBinder™ product line available from Organoclick® AB (which includes, for example, proteins, organic acids, and biopolymers from fruit peels, shrimp shells, corn, and potatoes). Non-limiting products include, for example, OC-BiobBinder™ Lotus and OC-BiobBinder™ Lily, both of which contain modified biopolymers and natural plant compounds. Other suitable bioadhesives are described in Organoclick AB's International Patent Application Publication No. WO2018 / 038671, the entire contents of which are incorporated herein by reference. In some embodiments, alternative adhesives may be classified as having "biodegradability," for example, as determined according to OECD 301A.
[0061] By incorporating the alternative adhesives described above into the wool fabric of oral products, the biodegradability and / or compostability of the wool fabric and / or oral products can be improved (compared to corresponding wool fabrics and / or oral products containing conventional synthetic adhesives). The biodegradability and / or compostability of the disclosed adhesives (and therefore, the biodegradability and / or compostability of the disclosed wool fabrics and oral products) can vary. Biodegradability and / or compostability may depend in part on the amount of non-biodegradable / non-compostable components present in the wool fabrics and oral products.
[0062] In some embodiments, the woolen materials and / or oral products provided herein can be described as substantially (or completely) free of TiO2. TiO2 is a common additive in woolen materials including synthetic fibers, acting as a matting agent. In some embodiments, it may be advantageous to prepare woolen materials that do not contain any significant amount of TiO2. "Substantially free" means that no TiO2 has been intentionally added. For example, some embodiments may be characterized as having less than 0.001% by weight of TiO2, or less than 0.0001% by weight, or even 0% by weight of TiO2.
[0063] Methods for producing woolen fabric materials
[0064] According to the present invention, the method for producing woolen fabric materials can vary. Web forming can be achieved by any means known in the art. The formation of a nonwoven web typically involves a carding step, which involves depositing fibers onto a surface and then aligning / mixing the fibers in a machine orientation. Subsequently, the web typically undergoes some type of bonding / entanglement, including but not limited to thermal bonding, mechanical entanglement, chemical bonding, or combinations thereof. In one embodiment, the web is thermally bonded using a calender (which can provide flat or dotted bonding), steam jet bonding, or a through-hole hot air oven. Other bonding methods include ultrasonic bonding and crimping. In some embodiments, needle punching is used, where needles are used to provide physical entanglement between fibers. In one embodiment, hydroentangling is used to entangle the web; hydroentangling is a process that uses hydrodynamics to wind and bond fibers. As mentioned above, in some embodiments, a first plurality of polymers present in the web can contribute to the consolidation of the woolen fabric in this step, therefore in some embodiments, this step includes heating the web to approximately T. m1 Or higher temperatures (preferably significantly lower than T) m2 For example, compared to T m2 At least about 20°C lower than T m2 At least about 30°C lower than T m2 At least about 30°C lower than T m2 At least 50°C lower than T m2 At least 60°C lower than T m2 At least 70°C lower than T m2 At least 80°C lower than T m2 At least 90°C lower, or higher than T m2 The temperature should be at least 100°C lower.
[0065] As described above, an adhesive material can be applied to the fibers of the fiber web before laying the fiber web, during fiber web formation, and / or after the fiber web is bonded to form the woolen material. After the woolen material is formed, heat can be applied to the woolen material to activate / at least partially melt the adhesive material, further bonding the woolen material and thus further enhancing the mechanical integrity of the woolen material. This heating can be, for example, at approximately T... m2 Or at a higher temperature.
[0066] The woolen fabric materials described herein can have different thicknesses, porosities, basis weights, and other parameters. The nonwoven web can be formed such that the fiber orientation and basis weight of the bagged product formed therefrom are capable of both retaining an oral composition within a permeable outer pouch encapsulating the composition and allowing the consumer to enjoy the flavor of the composition. For example, in some embodiments, the basis weight of the fiber web can be about 20 gsm to about 40 gsm, about 30 gsm to about 40 gsm, or about 25 gsm to about 30 gsm. In some embodiments, the fiber web can have a basis weight of about 28 gsm. The basis weight of the fabric can be measured, for example, using ASTM D3776 / D3776M-09a (2013) (Standard Test Method for Mass (Weight) of Fabrics per Unit Area). In some embodiments, the thickness of the fiber web can be from about 0.1 mm to about 0.3 mm (e.g., from about 0.1 to about 0.2 mm, e.g., about 0.11, 0.12, 0.13, 0.14, 0.15, 0.16, 0.17, or 0.18 mm). The elongation (MD / CD) of the fiber web can be greater than or equal to about 5%, e.g., greater than or equal to about 15%. In some embodiments, the fiber web can have a peak load of from about 4 psi to about 8 psi, e.g., about 5.5 psi. The elongation and breaking strength of the textile fabric can be measured using ASTM D5034-09 (2013) (Standard Test Method for Breaking Strength and Elongation of Textile Fabrics (Grab Test)). In some embodiments, the fiber web can have a tensile energy absorption (TEA) of from about 35 to about 40, e.g., about 37. For example, TEA can be measured as the work done to break the specimen under tensile load divided by the transverse area of the specimen.
[0067] Porosity is the percentage of voids in a material, usually expressed as a fraction, and varies widely. Air permeability is measured by the velocity of air flowing perpendicularly through a given area of fabric over a given time and at a given pressure difference across a given test area. For example, air permeability can be measured using methods such as NWSP 70.1 and / or ASTM D737-04 (2012) (standard test methods for air permeability of textile fabrics). In some embodiments, the fiber web can have a porosity greater than about 2000 ml / min / cm². 2 Or greater than approximately 10000 ml / min / cm 2 Breathability.
[0068] In some embodiments, the woolen material is provided or presented herein as a continuous material, such as a single-piece rolled woolen material. Therefore, woolen material is typically provided so that numerous bagged products can be subsequently produced from a single piece of woolen material.
[0069] oral products
[0070] The woolen fabric material with enhanced biodegradability described herein can be used to wrap oral compositions to form oral pouch products. Figure 1 The illustration generally depicts examples of bagged products comprising the disclosed woolen material according to some embodiments, wherein example bagged product 100 may include an outer water-permeable container 102 in the form of a pouch containing a woolen material containing an oral composition 104 suitable for oral use. It should be noted that various modifications can be made to the depicted embodiments, for example, replacing one or both serrated edges shown with straight edges.
[0071] In some embodiments, the oral composition 104 may be a particulate material. It is noteworthy that such a sachet is not limited to oral compositions containing a mixture of particles. In some embodiments, the material within the sachet suitable for oral use may be, for example, a liquid or gel material. In some embodiments, a breathable sachet or pouch may be used as a container for an oral composition (e.g., a particulate material). For example, the sachet provides a container permeable to liquids, the type of which can be considered similar in nature to the mesh material used to construct tea bags. If desired, flavoring ingredients, disintegration aids, and other desired components may be incorporated into or applied to the sachet material. Suitable packaging, sachets, or containers for manufacturing oral products may be modified according to this disclosure (e.g., incorporating the disclosed woolen materials), with trade names such as CatchDry, Ettan, General, Granit, Goteborgs Rape, Grosnus White, Metropol Kaktus, Mocca Anis, Mocca Mint, Mocca Wintergreen, Kicks, Probe, Prince, Skruf, and TreAnkrare. Pouch products with shapes and forms similar to some embodiments of the pouch products described herein are commercially available from ZONNIC (distributed by Niconovum AB). Furthermore, in Example 1 of PCT WO 2007 / 104573 by Axelsson et al., pouch-type products with shapes and forms generally similar to some embodiments of the pouch products are listed as snuff pouch compositions EJ, which is incorporated herein by reference and is produced using excipient ingredients and processing conditions suitable for manufacturing the pouch products described herein. Other types of nicotine-containing pouch products are sold under the VELO® brand.
[0072] There are no particular limitations on the oral composition 104 contained in this pouch product, and it may include any filling composition, including those that can be included in conventional wool-based pouch products. Such compositions are typically mixtures of two or more components, such as granular mixtures, and therefore, in some cases, these compositions are referred to as “mixtures” below.
[0073] Such mixtures may contain, for example, one or more active ingredients and / or one or more flavoring agents, as well as a variety of other optional ingredients (e.g., fillers, pH adjusters / buffers, colorants, humectants, salts, sweeteners, etc.). The disclosed mixtures may include a variety of additives; for example, the mixtures may be processed, mixed, formulated, combined, and / or mixed with other materials or ingredients. The additives may be artificial additives or may be derived from or derived from herbal or biological sources. Examples of other types of additives include thickeners or gelling agents (e.g., fish gelatin), emulsifiers, mouth care additives (e.g., thyme oil, eucalyptus oil, and zinc), preservatives (e.g., potassium sorbate, etc.), relatively water-soluble zinc or magnesium salts (e.g., magnesium gluconate or zinc gluconate) selected for compositions with high water solubility, or relatively water-insoluble zinc or magnesium salts (e.g., magnesium oxide or zinc oxide) selected for compositions with reduced water solubility, disintegrants, or combinations thereof. See, for example, U.S. Patent No. 9,237,769 to Mua et al., U.S. Patent No. 7,861,728 to Holton, Jr. et al., U.S. Patent Publication No. 2010 / 0291245 to Gao et al., and U.S. Patent Publication No. 2007 / 0062549 to Holton, Jr., and the manner and method of using those components, each of which is incorporated herein by reference. Typical ranges of the amount of such additives may vary depending on the nature and function of the additive and the intended effect on the final mixture, with exemplary ranges being up to about 10% by weight (e.g., about 0.1% to about 5% by weight) based on the total weight of the mixture.
[0074] The following outlines certain components that can be advantageously included in the mixture in some embodiments of the pouches provided herein; however, it should be understood that the following discussion is not intended to limit the components that can be included in the disclosed pouches. In some embodiments, the composition in the pouches provided herein comprises only saliva-soluble material. In some embodiments, the composition in the pouch is orally soluble. The composition can be configured to provide a sustained release of active ingredients and / or flavorings upon contact with the user's saliva. After use, in some such embodiments, the entire composition can completely dissolve, leaving only the woolen material (as described in detail above), exhibiting enhanced biodegradability upon disposal / composting. Thus, in some embodiments, substantially the entire oral product is biodegradable (e.g., within the time frame and conditions described above). In some embodiments, for example, when the biodegradable material constitutes only a portion of the woolen material, at least a portion of the woolen material is biodegradable (e.g., within the time frame and conditions described above). Therefore, the disclosed oral products can exhibit enhanced (including complete) biodegradability compared to corresponding oral products containing conventional woolen materials.
[0075] In some embodiments, the composition within the bagged product may be adapted or configured to dissolve at least partially or completely within a time period of about 5 minutes or longer, about 15 minutes or longer, about 30 minutes or longer, or about one hour or longer. In some embodiments, the composition may be configured to dissolve at least partially or completely within a time period of not less than 30 minutes, not less than 45 minutes, or not less than one hour. In some embodiments, the composition may be configured to dissolve at least partially or completely within a time period of about 30 seconds to about 30 minutes, about 1 minute to about 25 minutes, about 5 minutes to about 20 minutes, or about 5 minutes to about 15 minutes.
[0076] filler components
[0077] The oral composition within the pouch described herein may include at least one particulate filler component. Such particulate filler components can perform a variety of functions, such as enhancing certain sensory properties of the product (e.g., texture and mouthfeel), enhancing the product's cohesiveness or compressibility, etc. Typically, fillers are porous, particulate materials and are cellulose-based. Suitable fillers, for example, are any non-tobacco plant material or derivatives thereof, including cellulose materials derived from such sources. Examples of cellulose-based non-tobacco plant materials include cereals (e.g., corn, maize, oats, barley, rye, buckwheat, etc.), sugar beets (e.g., FIBREX® brand fillers available from International Fiber Corporation), bran fibers, and mixtures thereof. Non-limiting examples of non-tobacco plant material derivatives include starches (e.g., derived from potatoes, wheat, rice, corn), natural cellulose, and modified cellulose materials.
[0078] As used herein, “starch” can refer to pure starch, modified starch, or starch derivatives from any source. Starch is generally found in granular form in almost all green plants and in various types of plant tissues and organs, such as seeds, leaves, rhizomes, roots, tubers, buds, fruits, grains, and stems. The composition of starch, as well as the shape and size of its granules, can vary. Typically, starches from different sources have different chemical and physical properties. Specific starches can be selected for addition to mixtures based on their ability to impart specific sensory properties to a composition. Starches derived from a wide variety of sources can be used. For example, major sources of starch include cereals (such as rice, wheat, and corn) and root vegetables (such as potatoes and cassava). Other examples of starch sources include acorns, arrowroot, Peruvian carrots (arracacha), bananas, barley, legumes (e.g., broad beans, lentils, mung beans, peas, chickpeas), breadfruit, buckwheat, canna lilies, chestnuts, taro, katakuri, kudzu root, malanga, millet, oats, tuberous yams (oca), konjac (Polynesian arrowroot), sago, sorghum, sweet potatoes, quinoa, rye, cassava (tapioca), taro, tobacco, water chestnuts, and yams. Some starches are modified starches. Modified starches undergo one or more structural modifications, typically aimed at altering their high-temperature properties. Some starches are developed through genetic modification and are considered "modified" starches. Other starches are modified after acquisition. For example, modified starch can be starch that has undergone chemical reactions such as esterification, etherification, oxidation, depolymerization (thinning) by acid catalysis or oxidation in the presence of a base, bleaching, transglycosylation and depolymerization (e.g., dextrinization in the presence of a catalyst), crosslinking, enzymatic treatment, acetylation, hydroxypropylation, and / or partial hydrolysis. Other starches are modified by heat treatment, such as pregelatinization, dextrinization, and / or cold water swelling processes. Some modified starches include monosaccharide phosphate, distarch glycerol, distarch phosphate esterified with sodium trimetaphosphate, phosphorylated distarch phosphate, acetylated distarch phosphate, acetate starch esterified with acetic anhydride, acetate starch esterified with vinyl acetate, acetylated distarch adipate, acetylated distarch glycerol, hydroxypropyl starch, hydroxypropyl distarch glycerol, and sodium octenyl succinate starch.
[0079] Other examples of potential fillers include maltodextrin, glucose, calcium carbonate, calcium phosphate, lactose, and sugar alcohols. Combinations of fillers may also be used. In some embodiments, the filler comprises or is a mixture of glucose and starch-derived polysaccharides. One such suitable mixture of glucose and starch-derived polysaccharides is EMDEX®, available from JRS PHARMA LP, 2981 22nd Route, Paterson, NY, 12563-2359.
[0080] In some embodiments, the particulate filler is a cellulose material or a cellulose derivative. A particularly suitable particulate filler for use in the compositions described herein is microcrystalline cellulose (“mcc”). mcc may be synthetic or semi-synthetic, or it may be obtained entirely from natural cellulose. mcc may be selected from the group consisting of AVICEL® grades PH-100, PH-102, PH-103, PH-105, PH-112, PH-113, PH-200, PH-300, PH-302, VIVACEL® grades 101, 102, 12, 20, and EMOCEL® grades 50M and 90M, and mixtures thereof. In one embodiment, the composition comprises mcc as a particulate filler. The amount of mcc present may vary depending on desired properties.
[0081] The amount of filler can vary, but is typically at most about 90% by weight based on the total weight of the composition. Typical ranges for fillers (e.g., mcc) in the composition are from about 10 to about 85% by weight based on the total weight of the composition, for example, about 10, about 15, about 20, about 25, or about 30 to about 45, about 50, about 65, or about 75% by weight (e.g., about 20 to about 80% by weight or about 25 to about 75% by weight). In some embodiments, the amount of filler is at least about 10% by weight, for example, at least about 20% by weight, or at least about 25% by weight, or at least about 30% by weight, or at least about 40% by weight, or at least about 50% by weight, based on the total weight of the composition.
[0082] In one embodiment, the filler further comprises a cellulose derivative or a combination of such derivatives. In some embodiments, the composition comprises about 1 to about 10% by weight of a cellulose derivative based on the total weight of the composition, and some embodiments comprise about 1 to about 5% by weight of a cellulose derivative. In some embodiments, the cellulose derivative is a cellulose ether (including carboxyl ethers), which refers to a cellulose polymer in which one or more hydrogen atoms of the hydroxyl groups in the cellulose structure are replaced by alkyl, hydroxyalkyl, or aryl groups. Non-limiting examples of such cellulose derivatives include methylcellulose, hydroxypropylcellulose (“HPC”), hydroxypropyl methylcellulose (“HPMC”), hydroxyethylcellulose, and carboxymethylcellulose (“CMC”). In one embodiment, the cellulose derivative is one or more of methylcellulose, HPC, HPMC, hydroxyethylcellulose, and CMC. In one embodiment, the cellulose derivative is HPC. In some embodiments, the composition comprises about 1 to about 3% by weight of HPC based on the total weight of the composition.
[0083] Active ingredients
[0084] The compositions disclosed herein may comprise one or more active ingredients. As used herein, “active ingredient” means one or more substances belonging to any of the following categories: APIs (active pharmaceutical ingredients), food additives, natural medicines, and naturally occurring substances that can have effects on the human body. Exemplary active ingredients include any component known to affect one or more biological functions in the body, such as components that provide pharmacological activity or other direct effects in the diagnosis, cure, relief, treatment, or prevention of a disease, or components that affect any structure or function of the human body (e.g., providing stimulation to the central nervous system, having an energizing effect, antipyretic or analgesic effects, or producing other beneficial effects on the body). In some embodiments, the active ingredient may belong to the type commonly referred to as dietary supplements, nutritional supplements, “phytochemicals,” or “functional foods.” These types of additives are sometimes defined in the art as encompassing substances that are generally available from naturally occurring sources (e.g., plant materials) that provide one or more beneficial biological effects (e.g., promoting health, preventing disease, or other medicinal properties) but are not classified or regulated as drugs.
[0085] Non-limiting examples of active ingredients include those belonging to the categories of plant-based ingredients, stimulants, amino acids, and / or pharmaceuticals, nutritional supplements, and medicinal ingredients (such as vitamins, such as B6, B12, and C). Each of these categories is further described below. The specific selection of active ingredients will vary depending on the desired flavor, texture, and properties of the particular product.
[0086] The specific percentage of active ingredients present will vary depending on the desired properties of the particular product. Typically, the active ingredient or combination thereof is present at a total concentration of at least about 0.001% by weight of the composition, such as in the range of about 0.001% by weight to about 30% by weight. In some embodiments, based on the total weight of the composition, the active ingredient or combination of active ingredients is present at a concentration of about 0.1% w / w to about 10%, about 20%, or about 30% by weight, for example, about 0.5% w / w to about 30%, about 0.5% w / w to about 20%, about 0.5% w / w to about 10%, about 1% to about 10%, or about 1% to about 5% by weight. In some embodiments, the active ingredient or combination of active ingredients is present at a concentration of about 0.001 wt%, about 0.01 wt%, about 0.1 wt%, or about 1 wt% up to about 20 wt% based on the total weight of the composition, such as, for example, about 0.001 wt%, about 0.002 wt%, about 0.003 wt%, about 0.004 wt%, about 0.005 wt%, about 0.006 wt%, about 0.007 wt%, about 0.008 wt%, about 0.009 wt%, about 0.01 wt%, about 0.02 wt%, about 0.03 wt%, about 0.04 wt%, about 0.05 wt%, about 0.06 wt%. About 0.07 wt%, about 0.08 wt%, about 0.09 wt%, about 0.1 wt%, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt% or about 0.9 wt% to about 1 wt%, about 2 wt%, about 3 wt%, about 4 wt%, about 5 wt%, about 6 wt%, about 7 wt%, about 8 wt%, about 9 wt%, about 10 wt%, about 11 wt%, about 12 wt%, about 13 wt%, about 14 wt%, about 15 wt%, about 16 wt%, about 17 wt%, about 18 wt%, about 19 wt% or about 20 wt%. Further suitable ranges for specific active ingredients are provided below.
[0087] plant materials
[0088] In some embodiments, the active ingredient includes plant components. As used herein, the terms "plant component" or "plant material" refer to any plant material or fungal-derived material, including plant materials in their natural form and plant materials derived from natural plant materials, such as extracts or isolates from plant materials, or processed plant materials (e.g., plant materials subjected to heat treatment, fermentation, bleaching, or other treatment processes that alter the physical and / or chemical properties of the material). For the purposes of this disclosure, "plant-based" includes, but is not limited to, "herbal materials," which refers to seed-producing plants (e.g., tea or herbal tea) that do not develop durable lignin and are generally valued for their medicinal or sensory properties. The term "non-tobacco" for plant materials is intended to exclude tobacco materials (i.e., excluding any plants of the genus *Nicotiana*).
[0089] When present, the typical concentration of plant material is from about 0.01% w / w to about 10% by weight, such as, for example, based on the total weight of the composition, from about 0.01% w / w, about 0.05% by weight, about 0.1% by weight, or about 0.5% by weight to about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, or about 10% by weight, about 11% by weight, about 12% by weight, about 13% by weight, about 14% by weight, or about 15% by weight.
[0090] The plant materials useful in this disclosure may include, but are not limited to, any compounds and sources shown herein, including mixtures thereof. Some plant materials of this type are sometimes referred to as dietary supplements, nutritional supplements, “phytochemicals”, or “functional foods.” Certain plant materials are used in traditional herbal medicine in the form of plant materials or extracts thereof, and are further described herein.
[0091] Non-limiting examples of non-tobacco plant materials include, but are not limited to, acai berry ( Euterpe oleracea martius Acerola cherry ( Malpighia glabra ), alfalfa, allspice powder, angelica root, fennel (e.g., star anise), annatto seeds, apple ( Malus domestica ), apricot oil, ashwagandha, false purslane, baobab, basil ( Ocimum basilicum ), bay leaves, lemon balm, beetroot, bergamot, blackberry ( Morus nigra Black cohosh, black pepper, black tea, blueberries, black beans ( Peumus boldus Borage, sesame, cocoa, calamus root, kamok ( Myrcaria dubia Caraway seeds, cardamom, cassia seeds, catnip, calica, chili peppers, centella asiatica ( Centella asiatica), Chaga mushroom, Bupleurum chinense, Chamomile, cherry, custard apple, chives, chlorophyll, chocolate, coriander, cinnamon ( Cinnamomum cassia ), Citronella ( Cymbopogon citratus ), citrus, sage, cloves, coconut ( Cocos nucifera Coffee, purple gromwell leaves and roots, cordyceps, coriander seeds, cranberries, cumin, curcumin, damiana, dandelion, arisaema leaves (Liusang) Dorstenia arifolia ), Xiang Liusang ( Dorsteni odorata ), Echinacea, Elderberry, Elderflower, Dill ( Anethum graveolens Evening primrose, eucalyptus, fennel, chamomile, flax, tall fescue, garlic, ginger ( Zingiber officinale Ginkgo leaves, ginseng, goji berries, acacia, grape seeds, grapefruit, grapefruit rose ( Citrus paradisi ), Sourdough Sprout ( Annona muricata ), green tea, guarana, gutucola, hawthorn, hazelnut, hibiscus ( Hibiscus sabdariffa Honey tea, hops, arugula, goji berries ( Spilantes oleraceae ), Jasmine ( Jasminum officinale ), Juniper berries Juniperus communis ), Shannai ( Kaempferia parviflora (Thai ginseng), kava, laurel, lavender, lemon ( Citrus limon Lemon balm, lemongrass, licorice, cloves, lion's mane mushroom, lutein, maca ( Lepidium meyenii Nutmeg seed coat, marjoram, matcha, milk thistle, peppermint, mulberry, nard, nutmeg, olive, oolong tea, orange ( Citrus sinensis Oregano, papaya, chili powder, pepper, mint (peppermint), bell pepper, potato peel, primrose, quercetin, papaya, red clover, resveratrol, gastrodia elata, rhodiola rosea, rooibos (red or green), rosehip (dog rose), rosemary, saffron, sage, St. John's wort, sandalwood, sage (sage), salty, saw palmetto, jujube, schisandra chinensis, milk thistle, scutellaria baicalensis, spearmint, thorns, spirulina, slippery elm bark, sorghum bran, sorghum grains, spearmint ( Mentha spicata Spirulina, star anise, lacquer bark, tarragon, thyme, twig, turmeric, turnip ( Turnera aphrodisiaca Bearberry, valerian, herbs, and violets ( Viola odorata Wild yam root, holly, withania somnifera, yacon root, wrinkled sorrel, yerba mate, and yerba santa.
[0092] doping
[0093] In some embodiments, the active ingredient comprises one or more stimulants. As used herein, the term "stimulant" refers to a substance that increases the activity of the central nervous system and / or the body, for example, enhancing attention, cognition, energy, mood, alertness, etc. Non-limiting examples of stimulants include caffeine, theobromine, theobromine, and theophylline. Theobromine (1,3,7,9-tetramethyluric acid) is a purine alkaloid with a structure related to caffeine and has stimulant, analgesic, and anti-inflammatory effects. The stimulants present may be natural, naturally derived, or fully synthetic. For example, certain plant materials (guarana, tea, coffee, cocoa, etc.) may have stimulant effects due to the presence of, for example, caffeine or related alkaloids, and are therefore "natural" stimulants. "Naturally derived" means that the stimulant (e.g., caffeine, theobromine) is in a purified form, removed from its natural (e.g., plant-based) matrix. For example, caffeine can be obtained by extraction and purification from a plant source (e.g., tea). "Fully synthetic" means that the stimulant is obtained through chemical synthesis. In some embodiments, the active ingredient comprises caffeine. In some embodiments, the active ingredient is caffeine. In some embodiments, the caffeine is present in an encapsulated form. An example of encapsulated caffeine is Vitashure®, available from Balchem Corporation (52 Sunrise Park Road, New Hampton, NY 10958).
[0094] When present, the concentration of a stimulant or combination of stimulants (e.g., caffeine, theophylline, and combinations thereof) is typically from about 0.1% w / w to about 15% by weight based on the total weight of the composition, such as, for example, about 0.1% w / w, about 0.2% by weight, about 0.3% by weight, about 0.4% by weight, about 0.5% by weight, about 0.6% by weight, about 0.7% by weight, about 0.8% by weight, or about 0.9% by weight to about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, about 10% by weight, about 11% by weight, about 12% by weight, about 13% by weight, about 14% by weight, or about 15% by weight.
[0095] amino acids
[0096] In some embodiments, the active ingredient comprises amino acids. As used herein, the term "amino acid" refers to an organic compound containing amine (-NH2) and carboxyl (-COOH) or sulfonic acid (SO3H) functional groups, as well as the side chain (R group) characteristic of each amino acid. Amino acids can be protein amino acids or non-protein amino acids. "Proteinogenic" means that the amino acid is one of the twenty naturally occurring amino acids found in proteins. Proteinogenic amino acids include alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine. "Non-proteinogenic" means that the amino acid is either not naturally present in proteins or is not directly produced by cellular mechanisms (e.g., it is a product of post-translational modification). Non-restricted examples of non-proteinogenic amino acids include γ-aminobutyric acid (GABA), taurine (2-aminoethanesulfonic acid), theanine (L-γ-glutamylethylamine), hydroxyproline, and β-alanine.
[0097] When present, the concentration of amino acids or combinations of amino acids (e.g., taurine, theanine, and combinations thereof) is typically from about 0.1% w / w to about 15% by weight based on the total weight of the composition, such as, for example, about 0.1% w / w, about 0.2% by weight, about 0.3% by weight, about 0.4% by weight, about 0.5% by weight, about 0.6% by weight, about 0.7% by weight, about 0.8% by weight, or about 0.9% by weight to about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, about 10% by weight, about 11% by weight, about 12% by weight, about 13% by weight, about 14% by weight, or about 15% by weight.
[0098] Vitamins and / or minerals
[0099] In some embodiments, the active ingredient comprises a vitamin or a combination of vitamins. As used herein, the term "vitamin" refers to an organic molecule (or related group of molecules) of an essential micronutrient required for the normal functioning of metabolism in mammals. Human metabolism requires thirteen vitamins: vitamin A (such as all-trans retinol, all-trans retinol esters, and all-trans β-carotene and other provitamin A carotenoids), vitamin B1 (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), vitamin B7 (biotin), vitamin B9 (folic acid or folate), vitamin B12 (cobalamin derivatives), vitamin C (ascorbic acid), vitamin D (calciferol derivatives), vitamin E (tocopherols and tocotrienols), and vitamin K (quinones). In some embodiments, the active ingredient comprises vitamin C. In some embodiments, the active ingredient is a combination of vitamin C, caffeine, and taurine. In some embodiments, the active ingredient comprises one or more of vitamins B6 and B12. In some embodiments, the active ingredient includes theanine and one or more of vitamins B6 and B12.
[0100] When present, the vitamin or combination of vitamins (e.g., vitamin B6, vitamin B12, vitamin E, vitamin C, or combinations thereof) is typically present at a concentration of about 0.01% w / w to about 1% wt based on the total weight of the composition, such as, for example, about 0.01% w / w, about 0.02% w / w, about 0.03% w / w, about 0.04% w / w, about 0.05% w / w, about 0.06% w / w, about 0.07% w / w, about 0.08% w / w, about 0.09% w / w, or about 0.1% w / w to about 0.2% w / w, about 0.3% w / w, about 0.4% w / w, about 0.5% w / w, about 0.6% w / w, about 0.7% w / w, about 0.8% w / w, about 0.9% w / w, or about 1% w / w.
[0101] In some embodiments, the active ingredient comprises vitamin A. In some embodiments, the vitamin A is encapsulated. In some embodiments, the vitamin is vitamin B6, vitamin B12, vitamin E, vitamin C, or a combination thereof.
[0102] In some embodiments, the active ingredient comprises a mineral. As used herein, the term "mineral" refers to an inorganic molecule (or related group of molecules) that is an essential micronutrient required for the proper functioning of various systems in a mammalian body. Non-limiting examples of minerals include iron, zinc, copper, selenium, chromium, cobalt, manganese, calcium, phosphorus, sulfur, magnesium, etc. In some embodiments, the active ingredient comprises iron. Suitable sources of iron include, but are not limited to, ferrous salts, such as ferrous sulfate and ferrous gluconate. In some embodiments, the iron is present in an encapsulated form.
[0103] Terpenes
[0104] The active ingredients applicable to this disclosure can also be classified as terpenes, many of which are associated with biological effects, such as sedative effects. Terpenes are considered to possess (C5H8) n The general formula includes monoterpenes, sesquiterpenes, and diterpenes. Terpenes can be acyclic, monocyclic, or bicyclic in structure. Examples include β-caryophyllene, linalool, limonene, β-citronellol, linalyl acetate, pinene (α or β), geraniol, carvone, eucalyptol, menthone, isomenthone, piperonone, myrcene, β-bourbonene, and germacrene, which can be used alone or in combination.
[0105] In this regard, suitable terpenes include so-called "C10" terpenes (i.e., those comprising 10 carbon atoms) and so-called "C15" terpenes (i.e., those comprising 15 carbon atoms). In some embodiments, the active ingredient comprises more than one terpene. For example, the active ingredient may comprise one, two, three, four, five, six, seven, eight, nine, ten, or more terpenes as defined herein. In some embodiments, the terpenes are selected from pinene (α and β), geraniol, linalool, limonene, carvone, eucalyptol, menthone, isomenthone, piperonone, myrcene, β-boronene, gemmaene, and mixtures thereof.
[0106] antioxidants
[0107] In some embodiments, the active ingredient includes one or more antioxidants. As used herein, the term "antioxidant" refers to a substance that prevents or inhibits oxidation by terminating free radical reactions and can delay or prevent certain types of cell damage. Antioxidants can be naturally occurring or synthetic. Naturally occurring antioxidants include those found in foods and plant materials. Non-limiting examples of antioxidants include certain plant materials, vitamins, polyphenols, and phenol derivatives.
[0108] Examples of plant materials associated with antioxidant properties include, but are not limited to, acai berry, alfalfa, allspice powder, annatto seed, apricot oil, basil, propolis, wild bergamot, black pepper, blueberry, borage seed oil, bugleweed, cocoa, calamus root, catnip, cattuba, cayenne pepper, birch polypore, chervil, cinnamon, dark chocolate, potato peel, grape seed, ginseng, ginkgo, St. John's wort, saw palmetto, green tea, black tea, and black cohosh. Cohosh, Cayenne pepper, Chamomile, Clove, Cocoa powder, Cranberry, Dandelion, Grapefruit, Honey Tree Tea, Echinacea, Garlic, Evening Primrose, White Chrysanthemum, Ginger, Golden Seal, Hawthorn, Hibiscus, Gynostemma pentaphyllum, Kava, Lavender, Licorice, Marjoram, Milk Thistle, Peppermint, Oolong Tea, Beetroot, Orange, Oregano, Papaya, Pennyroyal, Peppermint, Red Clover, Rooibos Tea (Red or Green), Rosehip, Rosemary, Sage, Clary Sage, Peppermint, Spirulina, Smooth Elm Bark, Sorghum Bran (High Tannin), Sorghum Grain (High Tannin), Lacquer Tree Bran, Lithospermum Leaf and Root, Goji Berries, Centella Asiatica Kola, thyme, turmeric, bearberry, valerian, wild yam root, holly, snow lotus root, wrinkled sorrel, yerba mate, yerba mate, false purslane, withania somnifera, lion's mane mushroom, and milk thistle. These plant materials can be provided fresh, dried, or as essential oils, or as extracts. The plant materials (and their extracts) typically contain a variety of compounds known to provide antioxidant effects, such as minerals, vitamins, isoflavones, phytosterols, allyl sulfides, dithiothiophenes, isothiocyanates, indoles, lignans, flavonoids, polyphenols, and carotenoids. Examples of compounds present in plant extracts or oils include ascorbic acid, peanut endocarotene, resveratrol, sulforaphane, beta-carotene, lycopene, lutein, coenzyme Q, carnitine, quercetin, kaempferol, etc. See, for example, Santhosh et al., Phytomedicine, 12(2005) 216-220, which is incorporated herein by reference.
[0109] Other suitable antioxidants, without limitation, include citric acid, vitamin E or derivatives thereof, tocopherol, epicatechin, epigallocatechin, epigallocatechin gallate, isoascorbic acid, sodium isoascorbate, 4-hexylresorcinol, theaflavins, theaflavins monogallate A or B, theaflavins digallate, phenolic acids, glycosides, quercetin, isoquercetin, hyperoside, polyphenols, catechins, resveratrol, oleuropein, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), tert-butylhydroquinone (TBHQ), and combinations thereof.
[0110] When present, the concentration of the antioxidant is typically from about 0.001% w / w to about 10% by weight, such as, for example, about 0.001% by weight, about 0.005% by weight, about 0.01% w / w, about 0.05% by weight, about 0.1% by weight, or about 0.5% by weight, to about 1% by weight, about 2% by weight, about 3% by weight, about 4% by weight, about 5% by weight, about 6% by weight, about 7% by weight, about 8% by weight, about 9% by weight, or about 10% by weight (based on the total weight of the composition).
[0111] Nicotine components
[0112] "Nicolenic component" refers to any suitable form of nicotine (e.g., free base, salt, or ion pair) suitable for the oral absorption of at least part of the nicotine present. Nicotine is released from the composition, absorbed through the oral mucosa, enters the bloodstream, and circulates throughout the body. In some embodiments, the nicotine component may include two or more different nicotine components.
[0113] The source of nicotine may vary and can be natural or synthetic. Nicotine can be tobacco-derived (e.g., tobacco extract) or non-tobacco-derived (e.g., synthetic or otherwise obtained). In some embodiments, nicotine is naturally occurring and is derived from the genus *Nicotiana* (…). Nicotiana Nicotine is obtained from an extract of a species (e.g., tobacco). For example, nicotine may be in the form of a highly purified tobacco extract. Various methods for isolating and purifying nicotine from tobacco are known (including, but not limited to, extraction from tobacco with water; extraction from tobacco with organic solvents; steam distillation of tobacco; or pyrolysis of tobacco and distillation of nicotine therefrom). For exemplary extraction methods, see, for example, U.S. Patent Nos. 2,822,306 and 4,153,063 to Roselius et al. and U.S. Patent Application Publication No. 2008 / 0302377 to Kauryzbaev et al., which are incorporated herein by reference. In some embodiments, nicotine may be obtained from another source (e.g., another type of plant).
[0114] In some embodiments, nicotine may be synthetically prepared. The methods for synthesizing synthetic nicotine used in some embodiments of the compositions and products described herein can vary and are not particularly limited. Various methods for preparing nicotine are known. See, for example, Florence L. Wagner et al., 63. Tetrahedron 8065 (2007); US Patent No. 10,913,962, McCague et al.; and US Patent Application Publication No. 2020 / 0331884, Weber et al.
[0115] Nicotine can exist in enantiomeric forms: S(-)-nicotine, R(+)-nicotine, or a mixture of S(-)-nicotine and R(+)-nicotine. Nicotine may be in the form of S(-)-nicotine (e.g., practically all S(-)-nicotine), or may be a racemic mixture primarily or predominantly containing S(-)-nicotine (e.g., a mixture consisting of about 95 parts by weight of S(-)-nicotine and about 5 parts by weight of R(+)-nicotine). Nicotine is typically used in a nearly pure or substantially pure form, such as nicotine with a purity greater than about 95%, greater than about 98%, or greater than about 99% by weight.
[0116] Typically, the nicotine component is selected from the group consisting of: free nicotine bases, nicotine in ion-pair form, and nicotine salts. In some embodiments, at least a portion of the nicotine is in the form of a free base. In some embodiments, at least a portion of the nicotine is present in the form of a nicotine salt, or at least a portion of the nicotine is present in the form of an ion pair with at least a portion of an organic acid or its conjugate base, as further described below.
[0117] Alternatively, all or part of the nicotine component may be a nicotine polymeric complex. In some embodiments, such a complex comprises a polymeric resin (e.g., a polymeric ion exchange resin, such as a polymeric cation exchange resin) bound to nicotine. An example of such a resin is polymethacrylic acid, such as Amberlite IRP64, Purolite C115HMR, or Doshion P551. See, for example, U.S. Patent No. 3,901,248 to Lichtneckert et al., which is incorporated herein by reference. Another example is a nicotine-polyacrylic acid carbomer complex, such as Carbopol 974P. In some embodiments, nicotine may be present in the form of a nicotine-polyacrylic acid complex. An example of a suitable nicotine polymeric complex is a nicotine-polyacrylic acid resin complex (nicotine polacrilex), which contains nicotine bound to a resin prepared from methacrylic acid and divinylbenzene. Nicotine polyacrylate composites come in different percentages of nicotine, such as 18% to 20%; however, they are not limited to this, and nicotine polyacrylate composites typically contain not less than 95% of the labeled amount of nicotine, on an anhydrous basis.
[0118] In some embodiments, including nicotine components in the form of a nicotine polymer complex can improve shelf-life stability and slow nicotine release. In some embodiments, including nicotine components in the form of a nicotine polymer complex can reduce burning sensation in the mouth or throat during use. Based on the total weight of nicotine provided by all nicotine components in a given composition, the amount of nicotine provided by the nicotine polymer complex can vary between about 5%, about 10%, about 20%, about 30%, about 40%, about 50%, or about 60% and about 40%, 50%, about 60%, about 70%, about 80%, about 90%, about 95%, or 100%. Based on the total weight of the composition / mixture to be included in the pouched product, certain non-limiting example amounts of the nicotine polymer complex (including resin and nicotine) incorporated into a given composition can range, for example, from about 0.5% by weight to about 15% by weight, for example, from about 1% by weight to about 10% by weight, for example, from about 2% by weight to about 8% by weight.
[0119] Typically, the nicotine component (calculated as free base) is present at a concentration of at least about 0.001 wt% of the composition, such as in the range of about 0.001 wt% to about 10 wt%. In some embodiments, the nicotine component is present at a concentration of about 0.1% w / w to about 10 wt% (e.g., for example, about 0.1% w / w, about 0.2 wt%, about 0.3 wt%, about 0.4 wt%, about 0.5 wt%, about 0.6 wt%, about 0.7 wt%, about 0.8 wt%, or about 0.9 wt%, to about 1 wt%, about 2 wt%, about 3 wt%, about 4 wt%, about 5 wt%, about 6 wt%, about 7 wt%, about 8 wt%, about 9 wt%, or about 10 wt%), calculated as free base and based on the total weight of the composition. In some embodiments, the nicotine component is present at a concentration of about 0.1% w / w to about 3% by weight (such as about 0.1% w / w to about 2.5% by weight, about 0.1% by weight to about 2.0% by weight, 0.1% by weight to about 1.5% by weight, or about 0.1% by weight to about 1% by weight) based on free base and the total weight of the composition.
[0120] Drug ingredients
[0121] In some embodiments, the active ingredient includes an active pharmaceutical ingredient (API). The API can be any known agent suitable for therapeutic, preventative, or diagnostic purposes. These can include, for example, synthetic organic compounds, proteins and peptides, polysaccharides and other sugars, lipids, phospholipids, inorganic compounds (e.g., magnesium, selenium, zinc, nitrates), neurotransmitters or their precursors (e.g., serotonin, 5-hydroxytryptophan, oxysalicylate, acetylcholine, dopamine, melatonin), and nucleic acid sequences having therapeutic, preventative, or diagnostic activities. Non-limiting examples of APIs include analgesics and antipyretics (e.g., acetylsalicylic acid, acetaminophen, 3-(4-isobutylphenyl)propionic acid), phosphatidylserine, inositol, docosahexaenoic acid (DHA, ω-3), arachidonic acid (AA, ω-6), S-adenosylmethionine (SAM), β-hydroxy-β-methylbutyric acid (HMB), cytidine diphosphate choline (cytidine-5'-bisphosphate choline), and cotinine.
[0122] The amount of API can vary when present. For example, when present, the API is typically present at a concentration of about 0.001% w / w to about 10% wt% based on the total weight of the composition, such as about 0.01% w / w, about 0.02% w / w, about 0.03% w / w, about 0.04% w / w, about 0.05% w / w, about 0.06% w / w, about 0.07% w / w, about 0.08% w / w, about 0.09% w / w, about 0.1% w / w, about 0.2% w / w, about 0.3% w / w, about 0.4% w / w, about 0.5% w / w, about 0.6% w / w, about 0.7% w / w, about 0.8% w / w, or about 0.9% w / w, or about 1% w / w to about 2% w / w, about 3% w / w, about 4% w / w, about 5% w / w, about 6% w / w, about 7% w / w, about 8% w / w, about 9% w / w, or about 10% w / w.
[0123] Encapsulation and stabilization of active ingredients
[0124] In some embodiments, the active ingredients described herein may be sensitive to degradation (e.g., oxidative degradation, photolysis, thermal degradation, evaporation loss) during the processing or storage of the composition. In such embodiments, the active ingredients (such as caffeine, vitamin A, and iron (Fe)) may be encapsulated or otherwise modified by using suitable components (such as fillers, binders, etc.) to enhance the stability of the active ingredients. For example, binders, such as functional cellulose (e.g., cellulose ethers, including but not limited to hydroxypropyl cellulose) or alginate-based materials (e.g., cross-linked alginate), may be used to improve the degradation resistance of such active substances or to provide extended and / or separate delivery of the active ingredients. Additionally, these encapsulated active ingredients may need to be used in conjunction with excipients in the composition to increase their solubility and / or bioavailability. Non-limiting examples of suitable excipients include β-carotene, lycopene, vitamin D, vitamin E, coenzyme Q10, vitamin K, and curcumin.
[0125] In some embodiments, to provide the desired concentration of active ingredient by weight (%), the initial amount of active ingredient may be increased to compensate for losses due to gradual degradation. Therefore, this disclosure also considers larger initial amounts than those disclosed herein.
[0126] water
[0127] The water content of the composition (before consumer use) can vary depending on desired properties. Typically, the water content in the composition is less than about 60% by weight, usually from about 1% to about 60% by weight, for example, from about 5% to about 55% by weight, from about 10% to about 50% by weight, from about 20% to about 45% by weight, or from about 25% to about 40% by weight. In embodiments where the encapsulated pH adjuster is suitable for release in the presence of water, a lower water level may be required. In some embodiments, the composition contains less than about 20% by weight, for example, from about 15% by weight or less, from about 12% by weight or less, from about 10% by weight or less (e.g., from about 1% to about 20% by weight or from about 5% to about 15% by weight, based on the total weight of the composition).
[0128] organic acids
[0129] In some embodiments, the compositions disclosed herein comprise one or more organic acids. For example, the addition of organic acids can be used to lower the initial pH of the composition and / or can be used as ion-pair forming agents for nicotine. As used herein, the term "organic acid" refers to an organic (i.e., carbon-based) compound characterized by acidity. Typically, organic acids are relatively weak acids (i.e., they do not completely dissociate in the presence of water), such as carboxylic acids (-CO2H) or sulfonic acids (-SO2OH). As used herein, reference to organic acid means an intentionally added organic acid. In this respect, organic acids may be intentionally added as a specific compositional ingredient, rather than being inherently present merely as a component of another compositional ingredient (e.g., small amounts of organic acids may be inherently present in compositional ingredients such as tobacco materials).
[0130] Suitable organic acids will typically have a range of lipophilicity (i.e., a polarity that provides a suitable balance between water and organic solubility). Generally, as indicated by logP, the lipophilicity of a suitable organic acid will vary between about 1 and about 12 (more soluble in octanol than in water). In some embodiments, the logP value of the organic acid is from about 1 to about 12, for example, about 1.0, about 1.5, about 2.0, about 2.5, about 3.0, about 3.5, about 4.0, about 4.5, about 5.0, about 5.5, about 6.0, about 6.5, about 7.0, about 7.5 or about 8.0, to about 8.5, about 9.0, about 9.5, about 10.0, about 10.5, about 11.0, about 11.5 or about 12.0.
[0131] Without being bound by theory, it is believed that moderately lipophilic organic acids (e.g., logP of about 1.4 to about 4.5) react with nicotine to form polar ion pairs, thereby providing good octanol-water partitioning of said ion pairs, thus causing nicotine to partition into octanol rather than water. As discussed above, this partitioning into octanol indicates favorable oral bioavailability.
[0132] In specific embodiments, the logP value of the organic acid is from about 3.0 to about 8.0, about 10.0, or even 12.0. In some embodiments, for highly lipophilic organic acids (e.g., above about 4.5), the presence of certain solvents or solubilizers (e.g., glycerol or propylene glycol in the composition) may be beneficial in solubilizing the organic acid and its corresponding salt or ion pair with a basic amine.
[0133] In some embodiments, the organic acid is a carboxylic acid or a sulfonic acid. The functional group of the carboxylic acid or sulfonic acid may be linked to any alkyl, cycloalkyl, heterocycloalkyl, aryl, or heteroaryl group, having, for example, one to twenty carbon atoms (C1-C2). 20 In some embodiments, the organic acid is an alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl carboxylic acid or a sulfonic acid.
[0134] As used herein, "alkyl" refers to any straight-chain or branched hydrocarbon group. Alkyl groups can be saturated (i.e., entirely composed of...). sp 3 The carbon atom in the alkyl group can be present, or it can be unsaturated (i.e., having at least one unsaturated site). As used herein, the term "unsaturated" refers to the presence of carbon-carbon atoms at one or more positions within the alkyl group. sp 2 Double bonds. Unsaturated alkyl groups can be monounsaturated or polyunsaturated. Representative straight-chain alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, n-butyl, n-pentyl, and n-hexyl. Branched alkyl groups include, but are not limited to, isopropyl, sec-butyl, isobutyl, tert-butyl, isopentyl, and 2-methylbutyl. Representative unsaturated alkyl groups include, but are not limited to, ethylene (or vinyl), allyl, 1-butenyl, 2-butenyl, isobutenyl, 1-pentenyl, 2-pentenyl, 3-methyl-1-butenyl, 2-methyl-2-butenyl, 2,3-dimethyl-2-butenyl, etc. Alkyl groups can be unsubstituted or substituted.
[0135] As used herein, "cycloalkyl" refers to a carbocyclic group, which can be monocyclic or bicyclic. Cycloalkyl groups include monocyclic rings having 3 to 7 carbon atoms, or bicyclic rings having 7 to 12 carbon atoms. Examples of monocyclic cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Cycloalkyl groups can be substituted or unsubstituted and may contain one or more unsaturated sites (e.g., cyclopentenyl or cyclohexenyl).
[0136] As used herein, the term "aryl" refers to a carbocyclic aromatic group. Examples of aryl groups include, but are not limited to, phenyl and naphthyl groups. Aryl groups can be substituted or unsubstituted.
[0137] As used herein, “heteroaryl” and “heterocyclic alkyl” refer to aromatic or non-aromatic ring systems, respectively, in which one or more ring atoms are heteroatoms, such as nitrogen, oxygen, and sulfur. A heteroaryl or heterocyclic alkyl group comprises up to 20 carbon atoms and 1 to 3 heteroatoms selected from N, O, and S. A heteroaryl or heterocyclic alkyl group can be a monocyclic group having 3 to 7 ring members (e.g., 2 to 6 carbon atoms and 1 to 3 heteroatoms selected from N, O, and S), or a bicyclic group having 7 to 10 ring members (e.g., 4 to 9 carbon atoms and 1 to 3 heteroatoms selected from N, O, and S), such as bicyclic [4,5], [5,5], [5,6], or [6,6] systems. Examples of heteroaryl groups, as exemplary and not limiting, include: pyridyl, thiazolyl, tetrahydrothiophene, pyrimidinyl, furanyl, thiophene, pyrroleyl, pyrazolyl, imidazolyl, tetrazolyl, benzofuranyl, thianaphthyl, indoleyl, indoleenyl, quinolinyl, isoquinolinyl, benzimidazolyl, isoxazolyl, pyrazinyl, pyridazinyl, indoleazinyl, isoindoleyl, 3H-indoleyl, 1H-indazolyl, purineyl, 4 H-quinazinyl, phthalazinyl, naphridinyl, quinoxolinyl, quinazolinyl, cyclolinyl, pteridinyl, 4aH-carbazoyl, carbazoyl, phenanthridineyl, acridineyl, pyrimidinyl, phenanthridineyl, phenazinyl, phenothiazinyl, furazinyl, phenotoxazinyl, isochromyl, chromanyl, imidazoalkyl, imidazolinyl, pyrazolyl, pyrazolyl, benzotriazolyl, benzoisoxazolyl, and isatinoyl. Examples of heterocyclic alkyl groups, as exemplary and not limiting, include: dihydropyridyl, tetrahydropyridyl (piperidinyl), tetrahydrothiophenyl, piperidinyl, 4-piperidinoneyl, pyrrolyl, 2-pyrrolidoneyl, tetrahydrofuranyl, tetrahydropyranyl, bis(tetrahydropyran)yl, tetrahydroquinolinyl, tetrahydroisoquinolinyl, decahydroquinolinyl, octahydroisoquinolinyl, piperazineyl, quininecycloyl, and morpholinyl. Heteroaryl and heterocyclic alkyl groups may be substituted or unsubstituted.
[0138] As used herein and applicable to any of the alkyl, aryl, cycloalkyl, heteroaryl, or heterocyclic groups described above, "substituted" means that one or more hydrogen atoms are independently substituted by a substituent. Typical substituents include, but are not limited to, -Cl, -Br, -F, alkyl, -OH, -OCH3, NH2, -NHCH3, -N(CH3)2, -CN, -NC(=O)CH3, -C(=O)-, -C(=O)NH2, and -C(=O)N(CH3)2. Whenever a group is described as "optionally substituted," the group may be substituted by one or more of the above substituents, each chosen independently. In some embodiments, the substituent may be one or more methyl groups or one or more hydroxyl groups.
[0139] In some embodiments, the organic acid is an alkyl carboxylic acid. Non-limiting examples of alkyl carboxylic acids include formic acid, acetic acid, propionic acid, butyric acid, valeric acid, hexanoic acid, heptanoic acid, octanoic acid, nonanoic acid, decanoic acid, undecanoic acid, dodecanoic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, etc.
[0140] In some embodiments, the organic acid is an alkyl sulfonic acid. Non-limiting examples of alkyl sulfonic acids include propanesulfonic acid, heptanesulfonic acid, and octanesulfonic acid.
[0141] In some embodiments, the alkyl carboxylic acid or sulfonic acid is substituted with one or more hydroxyl groups. Non-limiting examples include glycolic acid, 4-hydroxybutyric acid, and lactic acid.
[0142] In some embodiments, the organic acid may include more than one carboxylic acid group or more than one sulfonic acid group (e.g., two, three, or more carboxylic acid groups). Non-limiting examples include oxalic acid, fumaric acid, maleic acid, and glutaric acid. In organic acids containing multiple carboxylic acid groups (e.g., two to four carboxylic acid groups), one or more of said carboxylic acid groups may be esterified. Non-limiting examples include monoethyl succinate, monomethyl fumarate, monomethyl citrate, or dimethyl succinate.
[0143] In some embodiments, the organic acid may include more than one carboxylic acid group and one or more hydroxyl groups. Non-limiting examples of such acids include tartaric acid, citric acid, etc.
[0144] In some embodiments, the organic acid is an aryl carboxylic acid or an aryl sulfonic acid. Non-limiting examples of aryl carboxylic acids and sulfonic acids include benzoic acid, methylbenzoic acid, salicylic acid, benzenesulfonic acid, and p-toluenesulfonic acid.
[0145] Other non-limiting examples of organic acids that can be used in some embodiments include: 2-(4-isobutylphenyl)propionic acid, 2,2-dichloroacetic acid, 2-hydroxyethanesulfonic acid, 2-oxoglutaric acid, 4-acetaminobenzoic acid, 4-aminosalicylic acid, adipic acid, ascorbic acid (L), aspartic acid (L), α-methylbutyric acid, camphoric acid (+), camphor-10-sulfonic acid (+), cinnamic acid, cyclohexylaminosulfonic acid, dodecyl sulfuric acid, ethane. -1,2-Disulfonic acid, ethanesulfonic acid, furoic acid, galactosic acid, gentic acid, glucoheponic acid, gluconic acid, glucuronic acid, glutamic acid, glycerophosphate, glycolic acid, hippuric acid, isobutyric acid, isovaleric acid, lactobionic acid, lauric acid, acetylpropionic acid, malic acid, malonic acid, mandelic acid, mesylic acid, naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, oleic acid, palmitic acid, pamoic acid, phenylacetic acid, pyroglutamic acid, pyruvic acid, sebacic acid, stearic acid, and undecenoic acid.
[0146] Examples of suitable acids include, but are not limited to, the list of organic acids in Table 1.
[0147] Table 1. Non-limiting examples of suitable organic acids Values obtained from PubChem or calculated.
[0148] In addition to considering logP value, the selection of organic acids can also depend on additional properties. For example, organic acids should be generally recognized as safe for human consumption and possess acceptable flavor, odor, volatility, and stability. Determining suitable organic acids is within the capabilities of those skilled in the art.
[0149] In some embodiments, the organic acid is a monoester of a dicarboxylic acid or a polycarboxylic acid. In some embodiments, the dicarboxylic acid is malonic acid, succinic acid, glutaric acid, adipic acid, fumaric acid, maleic acid, or a combination thereof. In some embodiments, the dicarboxylic acid is succinic acid, glutaric acid, fumaric acid, maleic acid, or a combination thereof. In some embodiments, the dicarboxylic acid is succinic acid, glutaric acid, or a combination thereof.
[0150] In some embodiments, the alcohol forming the monoester of the dicarboxylic acid is a lipophilic alcohol. Examples of suitable lipophilic alcohols include, but are not limited to, octanol, menthol, and tocopherol. In some embodiments, the organic acid is an octyl monoester of the dicarboxylic acid, such as octyl succinate, octyl fumarate, etc. In some embodiments, the organic acid is a monomenthyl ester of the dicarboxylic acid. Because certain menthyl esters can provide a cooling sensation when used in products containing the compositions described herein, they are suitable for use in the oral compositions described herein. In some embodiments, the organic acid is monomenthyl succinate, monomenthyl fumarate, monomenthyl glutarate, or combinations thereof. In some embodiments, the organic acid is a monotocopherol ester of the dicarboxylic acid. Because certain tocopherol esters can provide antioxidant effects, they are suitable for use in the oral compositions described herein. In some embodiments, the organic acid is tocopherol succinate, tocopherol fumarate, tocopherol glutarate, or combinations thereof.
[0151] In some embodiments, the organic acid is a carotenoid derivative having one or more carboxylic acid (groups). Carotenoids are tetraterpenes, meaning they consist of eight isoprene molecules and contain 40 carbon atoms. Therefore, they are generally lipophilic due to the presence of long unsaturated aliphatic chains and are typically yellow, orange, or red. Certain carotenoid derivatives can be advantageous in oral compositions because they both promote ion pairing and act as colorants in the composition. In some embodiments, the organic acid is (2E,4E,6E,8E,10E,12E,14E,16Z,18E)-20-methoxy-4,8,13,17-tetramethyl-20-oxoeicosano-2,4,6,8,10,12,14,16,18-nonenoic acid (annatto) or its isomers. annatto is produced from the annatto tree (*Annona squamosa*). Bixa orellana A carotenoid, a naturally occurring pigment found in the seeds of the annatto tree, provides its red-orange color. Natto is soluble in fats and alcohols but insoluble in water. When isolated, it is chemically unstable and undergoes isomerization to become the double-bonded isomer trans-annatto (β-annatto), with the following structure:
[0152] In some embodiments, the organic acid is (2E,4E,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethyleicosicocarbon-2,4,6,8,10,12,14,16,18-nonanediol (norannatin), which is a water-soluble hydrolysis product of annatin and has the following structure:
[0153] In some embodiments, more than one organic acid may be present. For example, the composition may include two, three, four, or more organic acids. Therefore, when "one organic acid" is mentioned herein, it also includes a mixture of two or more organic acids. The relative amounts of the various organic acids can vary. For example, the composition may contain equal amounts of two, three, or more organic acids, or it may contain different relative amounts. In this way, certain organic acids with logP values outside the desired range (e.g., citric acid or myristic acid) can be combined with other organic acids so that the average logP of the combination falls within the desired range. In some embodiments, it may be desirable to include organic acids with logP values outside the desired range in the composition for purposes such as, but not limited to, providing desired sensory properties, stability, or as a flavor component. Furthermore, certain lipophilic organic acids have undesirable flavor and / or aroma characteristics, which would make them unsuitable as the sole organic acid in a composition (e.g., present in equimolar or greater amounts relative to nicotine). Without being bound by theory, it is believed that combinations of different organic acids can provide the desired ion pairings, while the concentration of any single organic acid in the composition remains below a threshold that is considered sensorily unacceptable.
[0154] In some embodiments, the composition comprises an organic acid, which is a monoester of a dicarboxylic acid or a carotenoid derivative having one or more carboxylic acid groups as described above, and further comprises additional organic acids or salts thereof. In some embodiments, the additional organic acid is benzoic acid, its alkali metal salt, or a combination thereof.
[0155] In some embodiments, the composition comprises an alkali metal salt of an organic acid. For example, at least a portion of the organic acid may be present in the composition as an alkali metal salt. Suitable alkali metal salts include lithium, sodium, and potassium salts. In some embodiments, the alkali metal is sodium or potassium. In some embodiments, the alkali metal is sodium. In some embodiments, the composition comprises an organic acid and a sodium salt of the organic acid.
[0156] In some embodiments, the weight ratio of the organic acid to its sodium salt (or other alkali metal salt) is from about 0.1 to about 10, such as about 0.1, about 0.25, about 0.3, about 0.5, about 0.75, or about 1 to about 2, about 5, or about 10. For example, in some embodiments, both the organic acid and its sodium salt are added to the other components of the composition, wherein the added organic acid is in greater quantity than, equimolar with, or a fraction of the amount of sodium salt. Those skilled in the art will recognize that the relative amounts will be determined by the desired pH and ionic strength of the composition. For example, an amount of organic acid may be added to provide the desired pH level of the composition, while an amount of alkali metal (e.g., sodium) salt may be added to provide the desired degree of ion pairing. As those skilled in the art will understand, the amount of organic acid (i.e., in its protonated form) present in the composition relative to the amount of alkali metal salt or conjugate base present in the composition will vary depending on the pH of the composition and the pKa of the organic acid, as well as the actual relative amount initially added to the composition.
[0157] The amount of organic acid or its alkali metal salt present in the composition relative to a basic amine (e.g., nicotine) can vary. Generally, as the concentration of the organic acid (or its conjugate base) increases, the percentage of the basic amine (e.g., nicotine) ion-paired with the organic acid increases. This typically increases the extent to which the basic amine (e.g., nicotine) in ion-pair form is partitioned in octanol relative to water, as measured in logP (log10 of the partition coefficient). In some embodiments, the composition comprises about 0.05, about 0.1, about 1, about 1.5, about 2, or about 5 to about 10, about 15, or about 20 molar equivalents of the organic acid, its alkali metal salt, or combinations thereof, calculated as the free base of the basic amine (e.g., nicotine).
[0158] In some embodiments, the composition comprises, on a free base basis, about 2 to about 10, or about 2 to about 5 molar equivalents of the organic acid, its alkali metal salt, or combinations thereof relative to a basic amine (e.g., nicotine). In some embodiments, the organic acid, its alkali metal salt, or combinations thereof is present in a molar ratio of about 2, about 3, about 4, or about 5 to about 6, about 7, about 8, about 9, or about 10 to the basic amine (e.g., nicotine). In embodiments where more than one organic acid, its alkali metal salt, or both are present, it should be understood that such molar ratios reflect the total number of organic acids present.
[0159] In some embodiments, the amount of organic acid included is sufficient to provide a composition pH of about 4.0 to about 9.0, such as about 4.5 to about 7.0, or about 5.5 to about 7.0, about 4.0 to about 5.5, or about 7.0 to about 9.0. In some embodiments, the amount of organic acid included is sufficient to provide a composition pH of about 4.5 to about 6.5, for example, about 4.5, about 5.0, or about 5.5 to about 6.0 or about 6.5. In some embodiments, the organic acid is provided in an amount sufficient to provide a composition pH of about 5.5 to about 6.5, for example, about 5.5, about 5.6, about 5.7, about 5.8, about 5.9, or about 6.0 to about 6.1, about 6.2, about 6.3, about 6.4, or about 6.5. In some embodiments, an inorganic acid (e.g., hydrochloric acid, sulfuric acid, phosphoric acid, etc.) is added to adjust the pH of the composition to the desired value.
[0160] In some embodiments, the organic acid, as a free acid, is added to other composition components in pure substance form (i.e., in its solid or liquid state) or in a solution, such as in water. In some embodiments, an alkali metal salt of the organic acid is added to other composition components in pure substance form or in a solution, such as in water. In some embodiments, the organic acid and a basic amine (e.g., nicotine) are combined to form a salt before being added to the composition, or the salt is formed within the composition and exists therein as a salt. In some embodiments, the organic acid and the basic amine (e.g., nicotine) exist as separate components in the composition and form ion pairs upon contact with moisture (e.g., saliva from a user's mouth).
[0161] In some embodiments, the organic acid, as a free acid, is added to other composition components in pure substance form (i.e., in its solid or liquid state) or in a solution, for example, in water. In some embodiments, an alkali metal salt of the organic acid is added to other composition components in pure substance form or in a solution, for example, in water. In some embodiments, the organic acid and an active ingredient containing a basic amine (e.g., nicotine) are combined to form a salt before being added to the composition, or the salt is formed within the composition and exists therein as a salt.
[0162] Flavoring agent
[0163] In some embodiments, the compositions described herein comprise flavoring agents. As used herein, a “flavoring agent” or “flavoring agent” is any substance having a flavor or aroma capable of altering sensory properties associated with an oral product. Examples of sensory properties that can be altered by flavoring agents include taste, mouthfeel, moisture, and / or aroma / fragrance. For the avoidance of doubt, such flavoring agents are distinct from modifiers (such as sensory agents) disclosed herein. Flavoring agents can be natural or synthetic, and the flavor characteristics imparted therefrom can be described as, but are not limited to, fresh, sweet, herbal, candy, floral, fruity, or spicy.
[0164] Flavoring agents can be imitations, synthetic or natural ingredients or blends thereof. Flavoring agents may include naturally occurring flavoring materials, plants, plant extracts, synthetic materials or combinations thereof (e.g., tobacco, licorice, hydrangea, magnolia leaf, chamomile, fenugreek, maple syrup, matcha, Japanese mint, fennel seeds, turmeric, Indian spices, Asian spices, herbs, wintergreen, cherry, berries, red berries, cranberry, peach, apple, orange, mango, Clementine, lemon, lime, tropical fruits, papaya, rhubarb, grape, durian, dragon fruit, cucumber, blueberry, mulberry, citrus fruits, drambuie, bourbon whiskey, Scotch whiskey, whiskey, gin, tequila, rum, spearmint, peppermint, lavender, aloe vera, cardamom, celery, balsam, nutmeg, sandalwood, bergamot, geranium, chocolate, snuff, areca nut, hookah, pine, honey extract, rose oil, vanilla). Lemon oil, orange oil, orange blossom, cherry blossom, cinnamon, caraway, cognac, jasmine, ylang-ylang, sage, fennel, peppermint, ginger, coriander, coffee, peppermint oil from any species of the peppermint genus, star anise, cocoa, lemongrass, rooibos tea, flax, ginkgo, hazelnut, hibiscus, bay leaf, yerba mate, orange peel, rose, tea (such as green or black tea), thyme, juniper, elderflower, basil, bay leaf Cumin, oregano, chili powder, rosemary, saffron, lemon peel, mint, perilla, turmeric, coriander, myrtle, blackcurrant, valerian, pimento, nutmeg, damiana, marjoram, olive, lemon balm, lemon basil, chives, caraway, verbena, tarragon, limonene) and other additives such as charcoal, chlorophyll, minerals, plants, or breath fresheners.
[0165] Flavoring agents can be in any suitable form, such as liquids (e.g., oils), solids (e.g., powders), or gases. In some cases, flavoring agents may be provided in spray-dried or liquid form. In some embodiments, liquid flavoring agents are loaded in or on a porous particulate carrier (e.g., microcrystalline cellulose) (i.e., adsorbed or absorbed therein or on it) and then combined with other compositional components.
[0166] The amount of flavoring agent used in the composition may vary, but is typically up to about 10% by weight, and some embodiments are characterized by a flavoring agent content of at least about 0.1% by weight, such as about 0.5% to about 10%, about 1% to about 5%, or about 2% to about 4% by weight, based on the total weight of the composition.
[0167] Flavor modifiers
[0168] To improve the sensory properties of the compositions disclosed herein, the compositions may include one or more flavor modifiers (“flavor modifiers”) that can mask, alter, block, or improve the flavor of, for example, the compositions described herein. In some embodiments, the flavor modifier modulates one or more of bitterness, sweetness, saltiness, or sourness. In some embodiments, the compositions include an active ingredient having a bitter taste, and a flavor modifier that masks or blocks the perception of said bitterness. Suitable flavor modifiers include, but are not limited to, gamma-aminobutyric acid (GABA), adenosine monophosphate (AMP), lactosin, or combinations thereof.
[0169] When present, the representative amount of the flavor modifier is about 0.01% by weight or more, about 0.1% by weight or more, or about 1.0% by weight or more, but typically less than about 10% by weight of the total weight of the composition (e.g., about 0.01%, about 0.05%, about 0.1%, or about 0.5% to about 1%, about 5%, or about 10% by weight of the total weight of the composition).
[0170] Salt
[0171] In some embodiments, the composition may further comprise a salt (e.g., an alkali metal salt), typically used in an amount sufficient to provide the desired sensory properties to the mixture. Non-limiting examples of suitable salts include sodium chloride, potassium chloride, ammonium chloride, powdered salts, etc.
[0172] When present, the salt is typically present in amounts of about 0.5% by weight or more, about 1.0% by weight or more, or about 1.5% by weight or more, but generally constitutes about 10% or less, about 7.5% or less, or about 5% or less (e.g., about 0.5% to about 5% by weight) of the total weight of the composition.
[0173] sweeteners
[0174] To improve the sensory properties of the compositions according to this disclosure, one or more sweeteners may be added. The sweetener may be any sweetener or combination of sweeteners, and may be a natural sweetener, an artificial sweetener, or a combination of a natural sweetener and an artificial sweetener. Examples of natural sweeteners include fructose, sucrose, glucose, maltose, mannose, galactose, lactose, steviol glycosides, honey, etc. Examples of artificial sweeteners include sucralose, isomaltulose, maltodextrin, saccharin, aspartame, acesulfame potassium, neotame, etc. In some embodiments, the sweetener comprises one or more sugar alcohols. Sugar alcohols are polyols derived from monosaccharides or disaccharides through partial or complete hydrogenation. Sugar alcohols have, for example, about 4 to about 20 carbon atoms and include erythritol, arabinitol, ribitol, isomaltitol, maltitol, galactitol, idotitol, mannitol, xylitol, lactitol, sorbitol, and combinations thereof (e.g., hydrogenated starch hydrolysate). In some embodiments, the sweetener is sucralose, acesulfame potassium, or a combination thereof.
[0175] When present, the sweetener or sweetener combination may comprise from about 0.01 to about 20% by weight or more of the composition, for example, from about 0.01 to about 0.1%, from about 0.1 to about 1%, from about 1 to about 5%, from about 5 to about 10%, or from about 10 to about 20% by weight, based on the total weight of the composition. In some embodiments, the sweetener combination is present at a concentration of from about 0.01% to about 0.1% by weight of the composition, for example, from about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09%, or about 0.1% by weight of the composition. In some embodiments, the sweetener combination is present at a concentration of from about 0.1% to about 0.5% by weight of the composition, for example, from about 0.1%, about 0.2%, about 0.3%, about 0.4%, or about 0.5% by weight of the composition. In some embodiments, the sweetener combination is present at a concentration of about 1% to about 3% by weight of the composition.
[0176] pH adjuster
[0177] The mixture within the pouch may optionally contain one or more pH adjusters / buffers. Examples of usable pH adjusters and buffers include, but are not limited to, metal hydroxides (e.g., alkali metal hydroxides, such as sodium hydroxide and potassium hydroxide), and other alkali metal buffers, such as metal carbonates (e.g., potassium carbonate or sodium carbonate), or metal bicarbonates, such as sodium bicarbonate. When present, the buffer is typically present in an amount less than about 5% by weight of the membrane, for example, about 0.5% to about 5%, for example, about 0.75% to about 4%, about 0.75% to about 3%, or about 1% to about 2% by weight, based on the total weight of the mixture. Non-limiting examples of suitable buffers include alkali metal acetates, glycine salts, phosphates, glycerol phosphates, citrates, carbonates, bicarbonates, borates, or mixtures thereof.
[0178] Tobacco materials
[0179] In some embodiments, the composition may include tobacco material. The tobacco material may vary in species, type, and form. Generally, the tobacco material is derived from harvested tobacco varieties (…). NicotianaThe species are obtained from plants. Examples of plants in the genus *Nicotiana* include: *N. tabacum*, *N. rustica*, *N. alata*, *N. arentsii*, *N. excelsior*, *N. forgetiana*, *N. glauca*, *N. glutinosa*, *N. gossei*, *N. kawakamii*, *N. knightiana*, *N. langsdorffi*, *N. otophora*, *N. setchelli*, *N. sylvestris*, *N. tomentosa*, *N. tomentosiformis*, *N. undulata*, *N. xsanderae*, *N. africana*, and *N. clasping stem*. The following are listed: *N. amplexicaulis*, *N. benavidesii*, *N. bonariensis*, *N. debneyi*, *N. longiflora*, *N. maritina*, *N. megalosiphon*, *N. occidentalis*, *N. paniculata*, *N. plumbaginifolia*, *N. raimondii*, *N. rosulata*, *N. simulans*, *N. stocktonii*, *N. suaveolens*, *N. umbratica*, *N. velutina*, *N. wigandioides*, *N. acaulis*, *N. acuminata*, *N. narrow-leaved*. (N. attenuata), N. benthamiana, N. cavicola, N. clevelandii, N. cordifolia, N. corymbosa, N. fragrans, N. goodspeedii, N. linearis, N. moses.The species include *N. miersii*, *N. nudicaulis*, *N. obtusifolia*, *N. occidentalis subsp. Hersperis*, *N. pauciflora*, *N. petunioides*, *N. quadrivalvis*, *N. repanda*, *N. rotundifolia*, *N. solanifolia*, and *N. spegazzinii*. Other representative plants from the genus Nicotiana are shown in Goodspeed, *The Genus Nicotiana* (Chonica Botanica) (1954); U.S. Patent No. 4,660,577 to Sensabaugh, Jr. et al.; U.S. Patent No. 5,387,416 to White et al.; U.S. Patent No. 7,025,066 to Lawson et al.; U.S. Patent No. 7,798,153 to Lawrence, Jr.; and U.S. Patent No. 8,186,360 to Marshall et al.; all of which are incorporated herein by reference. Various types of tobacco, cultivation techniques, and harvesting techniques are described in *Tobacco Production, Chemistry and Technology* (1999) by Davis et al. (eds.), which is incorporated herein by reference.
[0180] Suitable tobacco materials can be obtained from tobacco plants derived using genetic modification or hybridization breeding techniques (e.g., tobacco plants can be genetically engineered or hybridized to increase or decrease the yield of components, traits, or attributes). See, for example, the types of plant genetic modifications shown in the following publications: U.S. Patent No. 5,539,093 to Fitzmaurice et al.; U.S. Patent No. 5,668,295 to Wahab et al.; U.S. Patent No. 5,705,624 to Fitzmaurice et al.; U.S. Patent No. 5,844,119 to Weigl; U.S. Patent No. 6,730,832 to Dominguez et al.; U.S. Patent No. 7,173,170 to Liu et al.; U.S. Patent No. 7,208,659 to Colliver et al.; and U.S. Patent No. 7,230,160 to Benning et al.; U.S. Patent Application Publication No. 2006 / 0236434 to Conkling et al.; and PCT WO2008 / 103935 to Nielsen et al. See also the tobacco types listed in U.S. Patent No. 4,660,577 to Sensabaugh, Jr. et al.; U.S. Patent No. 5,387,416 to White et al.; and U.S. Patent No. 6,730,832 to Dominguez et al., all of which are incorporated herein by reference.
[0181] In some embodiments, tobacco plants can be selected based on the abundance of various compounds present therein. For example, plants that produce higher amounts of one or more target isolated compounds can be selected. In some embodiments, tobacco plants (e.g., *Galpao communa*) are specifically cultivated for their rich leaf surface compounds. Tobacco plants can be grown in greenhouses, growing rooms, or in outdoor fields, or hydroponically.
[0182] Various parts or components of plants from the genus *Nicotiana* can be included in the compositions disclosed herein. For example, virtually all parts of the plant (e.g., the whole plant) can be harvested and used directly. Alternatively, various parts or segments of the plant can be harvested or separated after harvest for further use. For example, flowers, leaves, stems, culms, roots, seeds, and various combinations thereof can be separated for further use or processing. In some embodiments, the tobacco material comprises tobacco leaves (leaflets). The composition may include processed tobacco parts or fragments, substantially natural leaves, and / or stems in the form of cured and aged tobacco. In some embodiments, the tobacco material comprises solid tobacco material selected from the group consisting of leaves and stems. The tobacco used in the composition most preferably comprises tobacco leaves or a mixture of tobacco leaves and stems (wherein at least part of the leaves have been smoked). The tobacco component can be in a processed form, such as processed stems (e.g., cut-rolled stems, cut-rolled-expanded stems, or cut-puffed stems) or bulk-expanded tobacco (e.g., puffed tobacco, such as dry ice-expanded tobacco (DIET)). See, for example, the tobacco expansion processes shown in U.S. Patent No. 4,340,073 to de la Burde et al.; U.S. Patent No. 5,259,403 to Guy et al.; and U.S. Patent Nos. 5,908,032 and 7,556,047 to Poindexter et al., all of which are incorporated herein by reference. Furthermore, the composition can incorporate already fermented tobacco. See also the types of tobacco processing techniques shown in PCT WO2005 / 063060 to Atchley et al., which are incorporated herein by reference.
[0183] Tobacco material is typically used in the form of particles, such as chopped, milled, granulated, slurry, or powder. In some embodiments, the tobacco material is used in the form of portions or fragments with an average particle size of 1.4 mm to 250 micrometers. In some cases, the size of the tobacco particles can be set to pass through a sieve to obtain a desired particle size range. If desired, air grading equipment can be used to ensure that small-sized tobacco particles of the desired size or size range can be collected. If desired, granular tobacco fragments of different sizes can be mixed together.
[0184] The method of providing tobacco material in the form of finely crushed or powdered form can vary. Preferably, plant parts or fragments are ground, comminuted, milled, or pulverized into granular form using equipment and techniques for milling, grinding, etc. The plant or its parts may be subjected to external force or pressure (e.g., by pressing or rolling). When such processing is performed, the plant or its parts may have a moisture content close to its natural moisture content (e.g., the moisture content immediately after harvest), a moisture content obtained by adding water to the plant or its parts, or a moisture content resulting from the drying of the plant or its parts. For example, the plant or its parts or fragments that have been milled, crushed, milled, pulped, or ground may have a moisture content of less than about 25% by weight, typically less than about 20% by weight, and often less than about 15% by weight. Most preferably, the plant material is in a relatively dry state during the crushing or milling process using equipment such as hammer mills, cutting heads, air-controlled mills, etc. For example, when the moisture content of tobacco parts or fragments is less than about 15% by weight or less than about 5% by weight, it can be ground or milled.
[0185] The harvested tobacco plants are typically processed (curing). The tobacco materials included in the compositions disclosed herein are generally those that have been properly processed and / or aged. Various processing methods for various types of tobacco are described in Tobacco Production, Chemistry and Technology (1999) by Davis et al. (eds.), and examples of techniques and conditions for curing flue-cured tobacco are shown in Nestor et al., Beitrage Tabakforsch Int., 20, 467-475 (2003) and Peele's U.S. Patent No. 6,895,974, which are incorporated herein by reference. Representative techniques and conditions for air-curing tobacco include Groves et al.'s U.S. Patent No. 7,650,892; Roton et al., Beitrage Tabakforsch. Int. , 21, 305-320 (2005) and Staaf et al, Beitrage Tabakforsch. Int. As shown in , 21, 321-330 (2005), the literature is incorporated herein by reference. Certain types of tobacco can undergo alternative types of conditioning processes, such as smoked (smoked) or sun-dried (dried).
[0186] In some embodiments, the tobacco materials that may be used include flue-cured or Virginia tobacco (e.g., K326), burley tobacco, sun-dried tobacco (e.g., Indian Kurnool and aromatic tobacco, including Katerini, Prelip, Komotini, Xanthi and Yambol tobacco), Maryland tobacco, dark tobacco, dark flame-modified tobacco, dark air-modified tobacco (e.g., Madole, Passanda, Cubano, Jatin and Bezuki tobacco), light air-modified tobacco (e.g., North Wisconsin and Galpao tobacco), Indian air-modified tobacco, Red Russian and Rustica tobacco, as well as various other rare or specialty tobaccos and various blends of any of the aforementioned tobaccos.
[0187] The tobacco material may also be in a so-called "blended" form. For example, the tobacco material may include a mixture of portions or fragments of flue-cured tobacco, burley tobacco (e.g., Malawi burley tobacco), and aromatic tobacco (e.g., as tobacco composed of or derived from tobacco leaves, or a mixture of tobacco leaves and tobacco stems). For example, a representative blend may contain about 30 to about 70 parts of burley tobacco (e.g., leaves, or leaves and stems) and about 30 to about 70 parts of flue-cured tobacco (e.g., stems, leaves, or leaves and stems) by dry weight. Other exemplary tobacco blends may contain about 75 parts of flue-cured tobacco, about 15 parts of burley tobacco, and about 10 parts of aromatic tobacco by dry weight; or about 65 parts of flue-cured tobacco, about 25 parts of burley tobacco, and about 10 parts of aromatic tobacco; or about 65 parts of flue-cured tobacco, about 10 parts of burley tobacco, and about 25 parts of aromatic tobacco by dry weight. Other exemplary tobacco blends may contain about 20 to about 30 parts of aromatic tobacco and about 70 to about 80 parts of flue-cured tobacco by dry weight.
[0188] The tobacco materials used in this disclosure can be subjected to processes such as fermentation and bleaching. If desired, the tobacco materials can be subjected to controlled heat treatment, such as irradiation, pasteurization, or otherwise. Such treatment processes are detailed in, for example, U.S. Patent No. 8,061,362 to Mua et al., which is incorporated herein by reference. In some embodiments, the tobacco materials can be treated with water and an additive capable of inhibiting the reaction of asparagine to form acrylamide when the tobacco materials are heated (e.g., additives selected from the group consisting of: lysine, glycine, histidine, alanine, methionine, cysteine, glutamic acid, aspartic acid, proline, phenylalanine, valine, arginine, compositions containing divalent and trivalent cations, asparaginases, certain non-reducing sugars, certain reducing agents, phenolic compounds, certain compounds having at least one free thiol group or functionality, oxidizing agents, oxidation catalysts, natural plant extracts (e.g., rosemary extract) and combinations thereof). See, for example, the types of processing described in U.S. Patent Publications 8,434,496, 8,944,072, and 8,991,403 by Chen et al., the full text of which is incorporated herein by reference. In some embodiments, this type of treatment is useful where the previously described process requires heating of the raw tobacco material.
[0189] In some embodiments, the type of tobacco material is selected such that it is initially visually lighter in color than other tobacco materials (e.g., bleached or whitened). In some embodiments, the tobacco pulp can be whitened using any means known in the art. For example, bleached tobacco material produced by employing various bleaching agents or oxidants and oxidizing catalysts can be used. Exemplary oxidants include peroxides (e.g., hydrogen peroxide), chlorites, chlorates, perchlorates, hypochlorites, ozone, ammonia, potassium permanganate, and combinations thereof. Exemplary oxidizing catalysts are titanium dioxide, manganese dioxide, and combinations thereof.Processes for treating tobacco with bleaching agents are discussed, for example, in Daniels, Jr.'s U.S. Patent No. 787,611; Oelenheinz's U.S. Patent No. 1,086,306; Delling's U.S. Patent No. 1,437,095; Rosenhoch's U.S. Patent No. 1,757,477; Hawkinson's U.S. Patent No. 2,122,421; Baier's U.S. Patent No. 2,148,147; Baier's U.S. Patent No. 2,170,107; Baier's U.S. Patent No. 2,274,649; Prats et al.'s U.S. Patent No. 2,770,239; Rosen's U.S. Patent No. 3,612,065; R Rosen's U.S. Patent No. 3,851,653; Rosen's U.S. Patent No. 3,889,689; Minami's U.S. Patent No. 3,943,940; Rosen's U.S. Patent No. 3,943,945; Rainer's U.S. Patent No. 4,143,666; Campbell's U.S. Patent No. 4,194,514; Rainer et al.'s U.S. Patent Nos. 4,366,823, 4,366,824, and 4,388,933; Schmekel et al.'s U.S. Patent No. 4,641,667; Berger's U.S. Patent No. 5,713,376; Byrd Jr. et al.'s U.S. Patent No. 9,339,058; Beeson et al.'s U.S. Patent Nos. 9,420,825 and 10,772,349; and Byrd U.S. Patent No. 9,950,858 to Jr. et al.; and U.S. Patent Application Publication No. 2012 / 0067361 to Björkholm et al.; U.S. Patent Application Publication No. 2016 / 0073686 to Crooks; U.S. Patent Application Publication No. 2017 / 0020183 to Björkholm; and U.S. Patent Application Publication No. 2017 / 0112183 to Björkholm; and PCT Publication No. WO1996 / 031255 to Giolvas; WO2020128971 and WO2021048769 to McClanahan et al.; WO2013122948A1 to Beeson et al.; WO2018 / 083114 to Björkholm; and WO2021048768 and WO2021048770A1 to Zawadzki et al.; all of which are incorporated herein by reference.
[0190] In some embodiments, the whitening tobacco material may have an ISO brightness of at least about 50%, at least about 60%, at least about 65%, at least about 70%, at least about 75%, or at least about 80%. In some embodiments, the whitening tobacco material may have an ISO brightness in the range of about 50% to about 90%, about 55% to about 75%, or about 60% to about 70%. The ISO brightness can be measured according to ISO 3688:1999 or ISO 2470-1:2016.
[0191] In some embodiments, the bleached tobacco material can be characterized as being lighter in color (e.g., "bleached") compared to untreated tobacco material. White is typically defined with reference to the International Commission on Illumination (CIE) chromaticity diagram. In some embodiments, the bleached tobacco material can be characterized as being closer to pure white on the chromaticity diagram compared to untreated tobacco material.
[0192] Tobacco materials can be processed to remove at least some of the nicotine present. Suitable methods for extracting nicotine from tobacco materials are known in the art. In some embodiments, the tobacco material is substantially free of nicotine. "Substantially free" means that only trace amounts are present in the tobacco material. For example, in some embodiments, the tobacco material may be characterized as having less than 0.001% by weight, or less than 0.0001% by weight, or even 0% by weight of nicotine, based on the total weight of the tobacco material, calculated as free base.
[0193] The amount of tobacco material present can vary, and based on the total weight of the composition, the tobacco material is typically present in an amount of less than about 65%. For example, based on the total dry weight of the composition, the tobacco material may be present in amounts of about 0% by weight, about 0.1% by weight, about 0.5% by weight, about 1% by weight, about 5% by weight, about 10% by weight, about 15% by weight, about 20% by weight, about 25% by weight, about 30% by weight, or about 35% by weight to about 40% by weight, about 45% by weight, about 50% by weight, about 55% by weight, about 60% by weight, or about 65% by weight.
[0194] In some embodiments, the compositions of this disclosure may be characterized as completely or substantially free of any tobacco material (e.g., any embodiment disclosed herein may be completely or substantially free of any tobacco material). “Substantially free” means that no tobacco material has been intentionally added except in trace amounts naturally present in, for example, plant or herbal materials. For example, some embodiments may be characterized as having less than 0.5% by weight, less than 0.1% by weight, less than 0.01% by weight, or less than 0.001% by weight, or even 0% by weight of tobacco material based on the total wet weight of the composition.
[0195] In some embodiments, the products or compositions disclosed herein may be characterized by being free of any nicotine component (e.g., any embodiment disclosed herein may be completely or substantially free of any nicotine component). “Substantially free” means that no nicotine has been intentionally added except for trace amounts that may be naturally present in, for example, plant materials. For example, some embodiments may be characterized by containing less than 0.001% by weight of nicotine, or less than 0.0001% by weight of nicotine, or even 0% by weight of nicotine, calculated as free base.
[0196] Composite adhesives
[0197] In some embodiments, the composition may include a binder or combination of binders to provide the composition with desired physical properties and physical integrity, such as a thickener or gelling agent. Typical binders may be organic or inorganic, or combinations thereof. Representative binders include povidone, sodium alginate, starch-based binders, pectin, carrageenan, pullulan, zein, and combinations thereof. The binder may be used in an amount sufficient to provide the composition with the desired physical properties and physical integrity. The amount of binder used in the composition may vary, but is typically up to about 30% by weight, and some embodiments are characterized by a binder content of at least about 0.1% by weight, for example about 1% to about 30% by weight or about 5% to about 10% by weight, based on the total weight of the composition.
[0198] Other suitable adhesives include gums, such as natural gums. As used herein, natural gums refer to polysaccharide materials of natural origin that have adhesive properties and can also be used as thickeners or gelling agents. Representative natural gums derived from plants (which are usually water-soluble to some extent) include xanthan gum, guar gum, gum arabic, solanum, astragalus gum, ebony gum, locust bean gum, gellan gum, and combinations thereof. When present, natural gum adhesive materials are typically present in amounts of up to about 5% by weight, for example about 0.1, about 0.2, about 0.3, about 0.4, about 0.5, about 0.6, about 0.7, about 0.8, about 0.9, or about 1% to about 2, about 3, about 4, or about 5% by weight, based on the total weight of the composition.
[0199] Moisturizer
[0200] In some embodiments, one or more humectants may be used in the composition. Examples of humectants include, but are not limited to, polyols such as glycerin, propylene glycol, etc. When a humectant is included, it is typically provided in an amount sufficient to provide the desired moisture properties to the composition. Furthermore, in some cases, the humectant may impart the desired flow properties to the composition for deposition into a mold.
[0201] When present, the humectant typically constitutes about 5% or less of the composition by weight (e.g., about 0.5% to about 5% by weight). When present, a representative amount of the humectant is about 0.1% to about 1% by weight or about 1% to about 5% by weight, based on the total weight of the composition.
[0202] Colorant
[0203] Colorants may be used in an amount sufficient to provide the desired physical properties to the composition. Natural or synthetic colorants may be used, such as natural or synthetic dyes, food-grade colorants, and pharmaceutical-grade colorants. Examples of colorants include a variety of dyes and pigments, such as caramel color and titanium dioxide. Natural colorants such as curcumin, beet juice extract, and spirulina, as well as a variety of synthetic pigments, may also be used. The amount of colorant used in the composition can vary, but when present, it is typically up to about 3% by weight, for example, about 0.1%, about 0.5%, or about 1% to about 3% by weight, based on the total weight of the composition.
[0204] Oral care additives
[0205] In some embodiments, the composition comprises an oral care ingredient (or a mixture of such ingredients). Oral care ingredients provide the ability to inhibit tooth decay or loss, inhibit gum disease, relieve mouth pain, whiten teeth or otherwise inhibit tooth staining, stimulate saliva production, inhibit halitosis, freshen breath, etc. For example, effective amounts of ingredients such as thyme oil, eucalyptus oil, and zinc (e.g., ingredients available in ZYTEX® formulations from Discus Dental) may be incorporated into the composition. Other examples of ingredients that may be incorporated into the composition in desired effective amounts may include those incorporated into the types of oral care compositions shown below: Takahashi et al., Oral Microbiology and Immunology, 19(1), 61-64 (2004); Thistle’s U.S. Patent No. 6,083,527; and Jakubowski’s U.S. Patent Application Publication No. 2006 / 0210488 and Cummins et al.’s U.S. Patent Application Publication No. 2006 / 02228308. Other exemplary ingredients in tobacco-containing formulations include those found in formulations sold by Roquette as MALTISORB® and NatraRx as DENTIZYME®. When present, the representative amount of the oral care additive is at least about 1%, typically at least about 3%, and frequently at least about 5% of the total dry weight of the composition. The amount of the oral care additive in the composition typically does not exceed about 30%, typically does not exceed about 25%, and frequently does not exceed about 20% of the total dry weight of the composition.
[0206] Processing aids
[0207] If downstream processing of the composition (such as granulation, mixing, or molding) requires it, flow aids may also be added to the composition to enhance its flowability. In some embodiments, the composition (e.g., in melt and chewable forms) may be surface-treated with anti-sticking agents such as oils, silicones, etc. Exemplary flow aids include microcrystalline cellulose, silica, polyethylene glycol, stearic acid, calcium stearate, magnesium stearate, zinc stearate, sodium stearate, carnauba wax, and combinations thereof. In some embodiments, the flow aid is sodium stearate.
[0208] When present, the representative amount of the flow aid may be at least about 0.5% by weight or at least about 1% by weight of the total dry weight of the composition. Preferably, the amount of flow aid in the composition typically does not exceed about 5% by weight of the total dry weight of the composition, and often does not exceed about 3% by weight.
[0209] Other additives
[0210] Other additives may be included in the disclosed compositions. For example, the compositions may be processed, blended, formulated, combined, and / or mixed with other materials or ingredients. The additives may be artificial or derived from herbal or biological sources. Examples of other types of additives include thickeners or gelling agents (e.g., fish gelatin), emulsifiers, preservatives (e.g., potassium sorbate), disintegrants, or combinations thereof. See, for example, those representative components, combinations of components, relative amounts of those components, and methods of using those components shown in U.S. Patent No. 9,237,769 to Mua et al., U.S. Patent No. 7,861,728 to Holton, Jr. et al., U.S. Patent Application Publication No. 2010 / 0291245 to Gao et al., and U.S. Patent Application Publication No. 2007 / 0062549 to Holton, Jr., and are each incorporated herein by reference.
[0211] Typical ranges of the amount of such additives may vary depending on the nature and function of the additive and the expected effect on the final composition. An exemplary range is up to about 10% by weight (e.g., about 0.1% to about 5% by weight) based on the total weight of the composition.
[0212] The aforementioned additives may be used together (e.g., as an additive formulation) or separately (e.g., individual additive components may be added at different stages of the preparation of the final mixture). Furthermore, additives of the aforementioned types may be in encapsulated form in the final product or composition. Examples of encapsulated additives are described, for example, in Atchley's WO2010 / 132444, which has previously been incorporated herein by reference.
[0213] In some embodiments, the oral composition may be associated with a porous sponge. As used herein, "porous sponge" refers to a material having a large pore volume, generally capable of absorbing liquids, and exhibiting resilience. Sponges can be constructed from a variety of materials, including cellulose, synthetic polymers such as polyethylene, polyurethane, or Plastrazote® cross-linked polyethylene, rubber materials such as EPDM (ethylene propylene diene monomer), PVC / nitrile rubber, or neoprene rubber, silicone, etc. For the sake of brevity, the remainder of this disclosure focuses on cellulose sponge materials. However, the various characteristics and parameters associated with cellulose sponges herein may also be applied to other sponge materials.
[0214] Cellulose sponges can be formed using any method known in the art. In some embodiments, the sponge material comprises regenerated cellulose material. As known in the art, regenerated cellulose can be formed by removing non-cellulose compounds from wood, contacting the extracted wood with caustic soda, then with carbon disulfide, and then with sodium hydroxide to produce a viscous solution. Exemplary methods for preparing regenerated cellulose are provided in U.S. Patent No. 4,237,274 to Leoni et al.; U.S. Patent No. 4,268,666 to Baldini et al.; U.S. Patent No. 4,252,766 to Baldini et al.; U.S. Patent No. 4,388,256 to Ishida et al.; U.S. Patent No. 4,535,028 to Yokogi et al.; U.S. Patent No. 5,441,689 to Laity; U.S. Patent No. 5,997,790 to Vos et al.; and U.S. Patent No. 8,177,938 to Sumnicht, all of which are incorporated herein by reference.
[0215] Regenerated cellulose sponges are typically formed using a mixture of a regenerated cellulose solution as described above, reinforcing fibers such as flax, jute, cotton, regenerated cellulose fibers, and an inorganic pore-forming agent. Typically, this mixture is a viscous solution containing 5 to 8% by weight cellulose, 6 to 100% by weight reinforcing fibers based on the weight of cellulose, and 900 to 2500% by weight inorganic pore-forming agent based on the weight of cellulose. The pore-forming agent is usually composed of sodium sulfate decahydrate crystals or other alkali metal salts with high water of crystallization content, such as sodium acetate trihydrate, sodium carbonate decahydrate, trisodium phosphate dodecahydrate, disodium phosphate dodecahydrate, potassium sodium tartrate tetrahydrate, etc. The final pore size will depend on the size of the pore-forming agent crystals. If desired, colorants, such as dyes or pigments, can also be added to the mixture, or added to the sponge after formation, for example, by spraying the colorant onto the sponge or immersing the sponge in a colorant solution.
[0216] The mixture is then introduced into a desired mold or extruded through orifices of the desired shape and heated to coagulate and regenerate the cellulose solution and melt the pore-forming agent. After regeneration, the molded body is washed with water to remove soluble salts and other components, optionally desulfurized, optionally bleached, and optionally treated with a solution of plasticizers such as glycerol or propylene glycol. See, for example, WO2010105806 by Hunger et al., U.S. Patent No. 3,276,072 by Politzer et al., and U.S. Patent No. 3,131,076 by Richardson et al., which are incorporated herein by reference. Cellulose sponge materials are commercially available from suppliers such as Spontex.
[0217] The shape and size of the sponge can vary without departing from this disclosure. For example, the cellulose sponge can have a circular, rectangular, square, elliptical, triangular, or multi-lobed shape in cross-section. Its size should be suitable for insertion into the oral cavity.
[0218] Cellulose sponges typically have a density in the range of about 20 to about 60 kg / m³. Cellulose sponges generally exhibit high absorbency, with embodiments demonstrating the ability to absorb up to 20 times their dry weight (e.g., about 10 to about 20 times their dry weight). Exemplary pore size ranges include about 4 nm to about 1000 micrometers, for example, about 1 to about 500 micrometers or about 1 to about 100 micrometers.
[0219] In some embodiments, the cellulose sponges (and oral products made therefrom) provided herein are biodegradable and / or compostable. The term "biodegradable" as used with respect to plastic materials refers to polymers that degrade into carbon dioxide / methane, water, and biomass in the presence of bacteria, fungi, algae, and / or other microorganisms under aerobic and / or anaerobic conditions, although materials containing heteroatoms may also produce other products such as ammonia or sulfur dioxide. "Biomass" generally refers to portions of metabolic material that are incorporated into the existing cellular structure of living organisms, or portions that are converted into humic fractions indistinguishable from those of biologically derived materials. "Compostable" means that the material is designed to biodegrade under composting conditions (e.g., at temperatures below those of industrial composting facilities), and "oxidatively degradable" means that the material (typically containing suitable additives) breaks down into microplastics or decomposes through oxidative chemical processes.
[0220] Biodegradability can be evaluated, for example, by the weight loss of the oral product over time. In some embodiments, all biodegradable components achieve 100% biodegradability in time periods of less than 10 years, less than 5 years, less than 2 years, less than 1 year, or less than 6 months under ambient temperature (e.g., 20°C) and aerobic conditions; it should be understood that these time periods will be shortened upon exposure to elevated temperatures. Certain oral products described herein have been tested to meet the “biodegradable” requirements under the ASTM standards mentioned herein (e.g., according to one or more of ASTM D5338, ASTM D5511, ASTM D5526, ASTM D5988, ASTM D6400, and ASTM D6691), and / or the “easily biodegradable” standard specified in OECD 301B.
[0221] In some embodiments, the cellulose sponges and / or oral products provided herein can be described as substantially (or completely) free of TiO2. “Substantially free” means that no TiO2 has been intentionally added. For example, some embodiments may be characterized as having less than 0.001% by weight of TiO2, or less than 0.0001% by weight, or even 0% by weight of TiO2.
[0222] Cellulose sponges are treated with oral compositions. Oral compositions may include various components, such as active ingredients, flavoring agents, fillers, binders, humectants, sweeteners, salts, etc. Exemplary oral composition components are described in this disclosure.
[0223] Oral compositions can be associated with cellulose sponges in a variety of ways. For example, a cellulose sponge can be treated with a powder, solution, or slurry containing an oral composition, such as by soaking the cellulose sponge in an oral composition or by spraying the oral composition onto the sponge. In some embodiments, the oral composition is in the form of one or more capsules (e.g., microcapsules) containing an internal load comprising at least one component (e.g., an active ingredient or flavoring agent) intended for delivery to the oral cavity. The capsules may be contained in a slurry used to treat the cellulose sponge. Alternatively, the oral composition may be added during the formation of the cellulose sponge material, for example, by mixing the oral composition with a viscous cellulose solution prior to the molding step described above. The cellulose sponge carries the oral composition by coating its surface with the sponge surface and by absorbing it into the pores of the sponge.
[0224] In some embodiments, the oral composition is absorbed within and / or adsorbed onto the sponge material, wherein absorption is understood to refer to the process by which the oral composition (typically in liquid form) is drawn into the porous structure of the sponge, and adsorption is understood to refer to the process by which the oral composition accumulates as a surface layer on the sponge material.
[0225] Preparation of Compositions and Oral Products
[0226] The way the various components of a mixture are combined can vary. Accordingly, the overall mixture of the various components, such as powdered components, may be relatively homogeneous in nature. The components, which may be in liquid or dry solid form, may be mixed in a pretreatment step before being mixed with any remaining components of the mixture, or simply mixed with all other liquid or dry components. Any mixing technique or apparatus known in the art can be used to contact, combine, or mix the various components of the mixture. Any mixing method that brings the components of the mixture into close contact can be used, such as mixing devices with impellers or other structures capable of stirring. Examples of mixing equipment include feed drums, conditioning cylinders or conditioning rollers, liquid spray equipment, cone mixers, belt mixers, mixers supplied by Littleford Day, Inc. in models FKM130, FKM600, FKM1200, FKM2000, and FKM3000, plowshare mixing drums, Hobart brand mixers, etc. See also the types of methods described in, for example, U.S. Patent No. 4,148,325 to Solomon et al., U.S. Patent No. 6,510,855 to Korte et al., and U.S. Patent No. 6,834,654 to Williams, each of which is incorporated herein by reference. The manner and methods of preparing mixtures will be apparent to those skilled in the art. See, for example, the types of methods shown in, for example, U.S. Patent No. 4,148,325 to Solomon et al.; U.S. Patent No. 6,510,855 to Korte et al.; U.S. Patent No. 6,834,654 to Williams; U.S. Patent No. 4,725,440 to Ridgway et al., and U.S. Patent No. 6,077,524 to Bolder et al., each of which is incorporated herein by reference.
[0227] In some embodiments, the compositions of this disclosure are formed by first mixing any dry ingredients, including any filler components, optional salts, and any solid form of nicotine (e.g., nicotine polymer complexes). Subsequently, the liquid components of the composition are added to the dry mixture, for example by adding an aqueous solution containing soluble or miscible components, such as humectants, flavoring agents, and sweeteners. Subsequently, in some embodiments, it is advantageous to add an acid to lower the pH of the composition to a desired range, for example, a pH of about 4 to about 5. The amount of material contained in each product unit (e.g., sachets) can vary. In some embodiments, the weight of the composition in each sachet is at least about 50 mg, for example, about 50 mg to about 1 gram, about 100 to about 800 mg, or about 200 to about 700 mg. In some smaller embodiments, the weight of the composition in each sachet can be about 100 to about 300 mg. For larger embodiments, the weight of the composition in each sachet can be about 300 mg to about 700 mg. If desired, other components may be included in each sachet. For example, each pouch may contain at least one piece, strip, or sheet of flavored, water-dispersible, or water-soluble material (e.g., an edible film-type material for breath freshening), and may be placed in each pouch with or without at least one capsule. Such strips or sheets may be folded or crumpled for easy inclusion in the pouch. See, for example, U.S. Patent No. 6,887,307 to Scott et al. and U.S. Patent No. 6,923,981 to Leung et al.; and the types of materials and techniques shown in The EFSA Journal (2004) 85, 1-32, all of which are incorporated herein by reference in their entirety.
[0228] As described herein, woolen fabric materials exhibiting enhanced biodegradability can be used to form bagged products in various ways, for example, by providing a continuous supply of woolen fabric materials according to this disclosure; by sealing the side edges of the woolen fabric materials to form a continuous tubular member, thereby forming a longitudinally extending seam. For example, the seam can be formed by applying conventional heat-sealing techniques to the woolen fabric material, causing the heat-sealable adhesive material that may be present in the woolen fabric material to soften and / or melt to form a seal (e.g., at a temperature T). m2 (or above).
[0229] A filling of a composition suitable for oral use can be inserted into a continuous tubular member; the continuous tubular member can be cut at predetermined intervals to form a plurality of pouch portion, each pouch portion comprising the composition filling. Each discrete pouch portion can then be completely sealed to form an externally permeable pouch containing the woolen fabric material provided herein, which encloses the composition. This sealing step may involve applying conventional heat-sealing techniques to the pouch material (e.g., at temperature T). m2(or more), causing the heat-sealable adhesive material in the nonwoven web to soften and / or melt to form a seal. Sealing can also (or additionally) be performed by acoustic welding. Therefore, aspects of this disclosure are specifically configured to provide bagged products that are independent of each other. The order of the operations and method steps described herein should not be construed as limiting thereto.
[0230] Packaging equipment suitable for producing the oral products described herein can be any type of equipment used to encapsulate oral compositions in a fabric material to produce pouches. Non-limiting examples of such packaging equipment (also known as pouch packaging machines or pouch packers) include, for example, those manufactured by Merz Verpackungsmaschinen GmbH of Lich, Germany, and GDSpA, Italy, as well as those disclosed in U.S. Patent No. 11,284,643 to Carroll, U.S. Patent No. 10,870,503 to Garthaffner et al., U.S. Patent No. 8,151,802 to Boltrini, and U.S. Patent Application Publication No. 2010 / 0018539 to Brinkley et al., the entire contents of which are incorporated herein by reference. U.S. Patent Application Publication No. 2012 / 0055493 to Novak, III et al. Figure 1 -5 shows an example apparatus for manufacturing oral pouch products; however, this apparatus is used in a general and descriptive sense only and not for limiting purposes. It should also be understood that the following manufacturing processes and related equipment are not limited to the described process sequence. Pouch products may also include product identification information printed or dyed on the outer water-permeable pouch, or embossed (e.g., embossed, indented, or otherwise pressed) on the outer water-permeable pouch, as described in U.S. Patent Application Publication No. 2014 / 0255452, Reddick et al., which is incorporated herein by reference.
[0231] The woolen materials and oral products provided herein are advantageously biodegradable under certain conditions over a period of time, requiring a shorter time than corresponding woolen materials and oral products that do not contain the biodegradable fibrous components and / or bioadhesives (e.g., those comprising synthetic components) described herein. In some embodiments, substantially the entire oral product is biodegradable (i.e., at least the biodegradable fibrous components and / or bioadhesives) after use (and disposal or composting of the product). Therefore, the disclosed oral products can exhibit enhanced (including complete) biodegradability compared to corresponding oral products containing conventional woolen materials. As mentioned above, biodegradability can be evaluated, for example, by weight loss of the oral product over time. In some embodiments, all biodegradable components achieve 100% biodegradability in time periods of less than 10 years, less than 5 years, less than 2 years, less than 1 year, or less than 6 months under ambient temperature (e.g., 20°C) and aerobic conditions; it should be understood that these times will be shortened upon exposure to elevated temperatures. Certain oral care products described herein have been successfully tested as “biodegradable” according to the ASTM standards mentioned herein (the hair layer material according to one or more of ASTM D5338, ASTM D5511, ASTM D5526, ASTM D5988, ASTM D6400 and ASTM D6691) and / or according to the “easily biodegradable” standard of OECD 301B.
[0232] Many modifications and other embodiments of this disclosure will arise to those skilled in the art upon having benefited from the teachings presented in the foregoing description. Therefore, it should be understood that this disclosure is not limited to the specific embodiments disclosed, and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terminology is used herein, it is used only in a general and descriptive sense and not for limiting purposes.
Claims
1. A bagged product, comprising: A water-permeable pouch defining a cavity and a composition containing at least one water-soluble component within the cavity. The aforementioned water-permeable pouch comprises a woolen fabric material containing multiple fibers, wherein the multiple fibers include one or more structural fiber materials; and The aforementioned water-permeable pouch further includes one or more biodegradable components selected from: Various fibrous materials, including thermoplastic starch and / or polyhydroxyalkanoates; and Biodegradable adhesive components associated with the aforementioned fibers.
2. The bagged product of claim 1, wherein the plurality of fibers comprises one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates, and wherein the one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates are contained within the same fiber.
3. The bagged product of claim 2, wherein the plurality of fibers comprises fibers in the form of a sheath / core structure, the sheath component comprising thermoplastic starch and / or polyhydroxyalkanoates surrounding the core component, the core component comprising one or more structural fiber materials.
4. The bagged product of claim 3, wherein the core component comprising one or more structural fiber materials includes natural fiber materials selected from cotton, wool, cellulose, or cellulose derivatives (e.g., regenerated cellulose), particularly... The core component contains cellulose.
5. The bagged product of claim 2, wherein the one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates are in the form of a blend.
6. The bagged product of claim 1, wherein the plurality of fibers comprises one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates, and wherein the one or more structural fiber materials and thermoplastic starch and / or polyhydroxyalkanoates are contained within different fibers, and particularly Each of the different fibers is selected from single-component fibers and multi-component fibers.
7. The bagged product according to any one of claims 1-6, wherein the polyhydroxyalkanoate is selected from poly(3-hydroxybutyrate) (P(3HB)), poly(4-hydroxybutyrate) (P(4HB)) and poly(3-hydroxyvalerate) and their copolymers, derivatives and blends.
8. The bagged product of claim 7, wherein the polyhydroxyalkanoate is selected from poly-3-hydroxybutyrate-co-4-hydroxybutyrate, poly-3-hydroxybutyrate-co-valerate, and polyhydroxybutyrate-co-hexanoate, and blends of two or more thereof.
9. The bagged product according to any one of claims 1-8, wherein the polyhydroxyalkanoate is selected from: Short-chain PHA (SCL-PHA) with 3-5 carbon atoms in the monomer unit. Medium-chain PHAs (MCL-PHAs) with 6-14 carbon atoms in their monomer units; and Long-chain PHA (LCL-PHA) with more than 14 carbon atoms in the monomer unit.
10. The bagged product according to any one of claims 1-9, wherein the various fibrous materials comprising thermoplastic starch and / or polyhydroxyalkanoates include: The first plurality of fibers comprises a first polyhydroxyalkanoate having a first melting point, and The second multiple fibers contain a second polyhydroxyalkanoate having a second melting point different from the first melting point.
11. The bagged product of claim 10, wherein the first melting point and the second melting point differ by at least about 10°C.
12. The bagged product of claim 11, wherein the first melting point is below 75°C and the second melting point is above 125°C.
13. The bagged product of claim 10, wherein the first plurality of fibers includes a first sheath component surrounding a first core component, wherein the first sheath component includes a first polyhydroxyalkanoate, the second plurality of fibers includes a second sheath component surrounding a second core component, and wherein the second sheath component includes a second polyhydroxyalkanoate.
14. The bagged product of claim 13, wherein the first core component and / or the second core component comprises a natural fiber material selected from cotton, wool, cellulose, or cellulose derivatives (e.g., regenerated cellulose), particularly The natural fiber material mentioned above contains cellulose.
15. The bagged product of claim 1, wherein the thermoplastic starch comprises one or more starches derived from corn, cassava, wheat, rye, peas, sorghum, cassava, rice, calathea, sugar palm, or potato.
16. The bagged product of claim 1, wherein one or more structural fiber materials are selected from cotton, wool, cellulose and cellulose derivatives (e.g., regenerated cellulose).
17. The bagged product according to any one of claims 1-16, comprising a biodegradable adhesive component, particularly, The biodegradable binder components are derived from sources selected from corn or corn starch, potatoes, cassava, sugarcane bagasse, algae, fruit peels, shrimp shells, and combinations thereof, especially... The biodegradable adhesive components include modified biopolymers and natural plant compounds.
18. The bagged product as claimed in any one of claims 1-17, wherein the woolen material and / or the bagged product is substantially free of TiO2.
19. The bagged product according to any one of claims 1-18, wherein the woolen material is mainly composed of one or more structural materials and one or more biodegradable components.
20. The bagged product according to any one of claims 1-18, wherein the woolen material includes one or more additional components (e.g., additional fibers) in addition to one or more structural materials and one or more biodegradable components.
21. The bagged product of claim 20, wherein one or more additional components comprise biodegradable cellulose acetate fibers.
22. The pouched product according to any one of claims 1-21, wherein the oral composition comprises at least one of an active agent and a flavoring agent in an amount of at least about 0.5% by weight of the oral composition; and a filler in an amount of at least about 30% by weight of the oral composition.
23. The bagged product of claim 22, wherein the filler is selected from sugar substitutes, microcrystalline cellulose, and combinations thereof.
24. The bagged product according to any one of claims 1-23, wherein the woolen fabric material exhibits biodegradability according to one or more of ASTM D5338, ASTM D5511, ASTM D5526, D5988, ASTM D6400 and ASTM D6691.
Citation Information
Patent Citations
Smokeless tobacco products and processes
EP2635142A1
Whitened tobacco compostion
US10772349B2
Process of bleaching tobacco-leaves.
US1086306A
High speed poucher
US10870503B2
Process of making (S)-nicotine
US10913962B2
